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1. Abstract 
 
Central Nervous System (CNS) injuries and neurodegenerative diseases can lead to a critical 
loss of neurons and other nerve cells, which often in mammals cannot be regenerated by the 
organism itself. To recover the neural damage, great efforts are being undertaken in the field of 
neuronal reprogramming and other modes of repair. In order to execute neural repair, a thorough 
understanding of the underlying molecular mechanisms of neurogenesis is required. Although 
great strides have been made in uncovering key transcription factors and other modulators of 
neurogenesis, the emerging field of neuroepigenetics is still in its infancy. 
Many studies have individually highlighted the importance of novel and key players of embryonic 
and adult neurogenesis. However, less is known about similarities and differences between the 
molecular mechanisms underlying neurogenesis at these two stages. To shed light on these 
processes, we decided to employ a candidate approach, focusing on a factor which is expressed 
highly in both embryonic and adult neural stem cells and progenitors and downregulated in 
differentiated cells. Our rationale was that such a factor could play a key role in instructing 
neurogenesis and allow a comparison of embryonic and adult neurogenesis.  
To identify new factors playing roles in neurogenesis, we mined data from transcriptional profiling 
carried out by our lab previously. Our lab designed protocols to isolate embryonic progenitors 
from the developing cerebral cortex (Pinto et al. 2008) and adult neural stem cells (NSCs) and 
their progeny from the subependymal zone (SEZ) (Beckervordersandforth et al. 2010; Fischer et 
al. 2011). From these data, we screened for epigenetic regulators of neurogenesis and identified 
Uhrf1 (Ubiquitin-like with PHD and RING Finger Domain 1).  Uhrf1 is a multi-domain protein, 
described to play a role in DNA methylation, histone methylation and ubiquitination. Previous data 
from our lab indicated that Uhrf1 is highly expressed in the embryonic cortex by progenitors and 
adult neural stem cells in development and adulthood and played an important role in 
neurogenesis (Bayam. 2014).  
We observed that loss of Uhrf1 in the developing cortex primarily resulted in impaired terminal 
neuronal differentiation, culminating in severe postnatal death. Surprisingly, we did not observe 
significant changes in cell fate, progenitor proliferation or initial neuronal differentiation. Analysis 
of transcriptional changes largely mirrored the cellular phenotypes observed. Additionally, we 
could identify transcriptional programs related to cellular stress to be activated in the cortical 
conditional knockout (cKO) of Uhrf1. The most striking effects we observed were in the activation 
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of specific retroviral elements (type of transposable element) known as IAPs in the cKO, which 
are normally silenced in control animals. We determined a loss of DNA methylation of several 
loci, including several groups of transposable elements. Interestingly, we could detect a selective 
increase of 5-hydroxy methyl cytosine (5hmC, a mark associated with transcriptional activation) 
on Intracisternal A-Particles (IAPs), as opposed to other elements. We could perform molecular 
rescue experiments to elucidate interplay between Uhrf1 and Tet enzymes in the regulation of 
IAP elements, in cortical neural stem cells.  
To examine the role of Uhrf1 in adult neurogenesis we used the GlastcreERT2 mice (Mori et al. 
2006) and CAG reporter mice (Nakamura et al. 2006) to inducibly delete Uhrf1 in adult neural 
stem cells and all their progeny. As opposed to the role of Uhrf1 in embryonic neurogenesis, we 
observed strong changes in progenitor proliferation in the adult cKO of Uhrf1 in the SEZ. 
Moreover, in contrast to embryonic stages, we could not detect significantly altered cell death in 
the adult cKO. Analysis of the molecular role of Uhrf1 in this niches, uncovered a surprising 
difference in IAP regulation between the SEZ and dentate gyrus. Although we detected 
upregulation of IAP structural proteins in the SEZ cKO, this was not the case in the dentate gyrus 
cKO.  However, the dentate gyrus adult neurogenesis was severely impaired, with much reduced 
proliferation and neuroblasts. Thus, the cellular and molecular function of Uhrf1 is clearly different 
in adult neurogenesis compared to development. 
The data from my thesis allowed us to draw several key conclusions regarding the molecular role 
of Uhrf1. Firstly, we observed specificity in regulation of retroviral elements by Uhrf1 in the 
embryonic cortex and adult SEZ. Secondly, we uncovered a role for factors expressed in early 
neural stem cells (in this case, Uhrf1) to exert long-term effects on their progeny. Altogether, our 
data implicate an important unique function for Uhrf1 in neurogenesis and further research can 
indicate its relevance in the fields of reprogramming and repair. 
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2. Introduction 
 
2.1 Epigenetic regulators of neurogenesis 
Epigenetics is the study of changes that occur in the DNA of a cell which affects gene expression 
without modifying the original genetic code. The changes affect two classes of molecules – either 
histones or DNA. The histones or DNA undergo certain modifications by methylation, acetylation 
or other chemical modifications. Such modifications can either positively affect transcription, thus 
termed ‘activating’, or negatively affect transcription, termed ‘repressive’. Epigenetic marks occur 
on chromatin which is composed of nucleosomes (complex of histones and DNA) (Figure 2-1). 
Chromatin conformation can vary from being tightly packaged (as observed in heterochromatin) 
or as an open conformation (often occurring in euchromatin). Open chromatin is accessible for 
transcription factors and is thus considered to be more transcriptionally active than the closed 
conformation.  
Epigenetics has been described to play important roles in cellular processes such as proliferation 
and differentiation, in several cell types in tissues. One such region is the embryonic and adult 
brain, wherein residing stem cells generate neurons, a process known as neurogenesis. 
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Fig. 2-1 Chromatin conformation showing epigenetic modifications 
Adapted by permission from Macmillan Publishers Ltd: Nature (Marx 2012) copyright (2012). 
License no. 4050260546065.  
Chromosomes are packaged in cells in the form of chromatin which comprise of nucleosomes 
containing histones and DNA. Chromatin can be both open and closed and modified by 
epigenetic modifications such as DNA methylation and modified histone tails. 
 
 
Most of the studies in neurogenesis have focused on the role of signaling pathways, transcription 
factors and cytoplasmic/membrane related proteins. For example, the transcription factors Pax6, 
Arx and Lhx2 have been shown to be control NSC proliferation and differentiation (Manuel et al. 
2015). Moreover, the bHLH family of transcription factors such as Ngn2 and Ascl1 have been 
described to act as important regulators of neurogenesis (Schuurmans and Guillemot 2002; 
Wilkinson et al. 2013). Certain signaling pathways acting upstream of the transcription factors 
have also been described to control stem cell renewal and proliferation, such as Notch, FGF and 
Wnt signaling (Martynoga et al. 2012). However, there has been a recent burst of publications 
illuminating the importance of chromatin and epigenetic factors in both embryonic and adult 
neurogenesis. 
Chromatin remodelers such as the SWI-SNF complex have been described to control neuronal 
differentiation in the embryonic cerebral cortex, as well as cell fate in an adult neurogenic niche, 
SEZ (Matsumoto et al. 2006; Ninkovic et al. 2013). Epigenetic regulators such as those controlling 
histone methylation and DNA methylation can also regulate neurogenesis. Components of the 
polycomb repressor complex, which are involved in setting the H3K27me3 mark, such as Ezh2 
or Ring1b have been described to regulate cerebral cortical neurogenesis (Fasano et al. 2007; 
Hirabayashi et al. 2009; Pereira et al. 2010). Moreover, ESET and Kap1, both involved in setting 
the H3K9me3 mark, have also been implicated in cerebral cortical neuron differentiation (Tan et 
al. 2012; Fasching et al. 2015). Besides histone methylation, components of the DNA methylation 
machinery can impact neuronal survival. The DNA methyltransferases, Dnmt1, Dnmt3a and 
Dnmt3b have been described to ensure appropriate cortical neuron numbers and neuronal 
maturation (Hutnick et al. 2009; Feng et al. 2010). Recent data have also implicated the role of 
                                                                                                                                                                     Introduction 
 
5 
 
non-coding elements such as non-coding RNA and micro RNA in regulation of neurogenesis 
(Iyengar et al. 2014). 
 
2.1.1 Histone marks and their role in neurogenesis 
The main histone marks which are ‘activating’ in terms of transcription are acetylation of H3K27 
in enhancers (Creyghton et al. 2010) and H3K9 in promoters (Koch et al. 2007) and methylation 
of H3K4 in promoters (Benevolenskaya 2007; Koch et al. 2007) (Figure 2-2). In contrast, tri-
methylation of H3K9 and H3K27 in genes (Barski et al. 2007) are considered largely repressive 
marks. These modifications are carried out by specific enzymes which can acetylate histones (eg. 
p300), deacetylate histones (eg. HDAC1) and methylate histones (eg. Setdb1).  
Two of the repressive histone marks which have been widely studied in neurogenesis are 
H3K9me3 and H3K27me3. H3K9me3 is set by a complex of ESET or Setdb1 which acts a histone 
methyl transferase and Trim28 or Kap1 which acts a co-factor (Schultz et al. 2002). 2002). Both 
Setdb1 and Kap1 are expressed by embryonic NSCs in the cerebral cortex (Tan et al. 2012; 
Fasching et al. 2015). Conditional deletion of Setdb1 in the embryonic cortex resulted in defects 
in neuronal differentiation and proliferation (Tan et al. 2012), suggesting an important role for 
histone methylation in neurogenesis. Moreover, conditional deletion of both Setdb1 and Kap1 
resulted in activation of transposable elements (Tan et al. 2012; Fasching et al. 2015).  
H3K27me3 is regulated by the polycomb repressive complex PRC1 and PRC2 (Cao et al. 2002; 
Cao and Zhang 2004; Leeb et al. 2010; Simon and Kingston 2013). Loss of certain components 
of the polycomb machinery led to defects in neurogenesis. Conditional deletion of Bmi-1 in adult 
NSCs, both in vitro and in vivo, affects their maintenance (Molofsky et al. 2003). However, acute 
deletion of Bmi-1 in embryonic neural stem cells does not affect progenitor proliferation (Fasano 
et al. 2007). These data highlight an importance difference between NSCs during development 
and adult and between in vitro/in vivo experiments. Conditional deletion of Ezh2 and Ring1b in 
cortical NSCs leads to a prolongation of the usual period of neurogenesis in this region 
(Hirabayashi et al. 2009). However, early deletion of Ezh2 prior to neurogenesis disturbs the 
balance between proliferation and differentiation in the cerebral cortex (Pereira et al. 2010). 
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Fig. 2-2. Activated and repressed gene promoters and gene bodies by histone 
modifications. Adapted by permission from Macmillan Publishers Ltd: Nature (Zhou et al. 2011) 
copyright (2011). License no. 4050271026920 
A. Active promoters often contain H3K4me3 and repressed promoters contain high levels of 
H3K9me3 and H3K29me3.  
B. Genes bodies vary in different histone marks depending on active and inactive regions. In 
particular, exons of active genes often contain high levels of H3K36me3. 
 
 
2.1.2 DNA modifications  
The other key group of epigenetic modifications are DNA modifications. The main type of DNA 
modification identified and studied till date is that of DNA methylation. DNA methylation involves 
the addition of a methyl group to the fifth carbon atom of the cytosine residue which lies adjacent 
to a guanine residue. This mode of methylation is an active process which is carried out by a 
group of enzymes termed DNA methyl transferases (Dnmts). There are 5 known Dnmts – Dnmt1, 
Dnmt3a, Dnmt3b, Dntm3c and Dnmt3L. Dnmt3a and Dnmt3b act as de novo methyltransferases 
which initially adds the methyl group to unmethylated cytosine on both strands of DNA (Bird 1999). 
Dnmt3L lacks the catalytic domain of other Dnmts but is important for establishing imprinting 
control regions in gametes (Bourc'his et al. 2001; Bourc'his and Bestor 2004). Recently, a new 
Dnmt member, Dnmt3c, has been described in male germ cells to arise from a duplication of 
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Dnmt3b (Barau et al. 2016).  On the other hand, Dnmt1 is a maintenance methyl transferase 
which adds the methyl group to the newly synthesized DNA strand wherein the other older strand 
is already methylated (Bird 1999). Studies have indicated another molecule, Uhrf1 (Ubiquitin-like 
with PHD and RING finger domains) to play a crucial role in DNA methylation. Uhrf1 binds 
hemimethylated DNA (Arita et al. 2008) as well as Dnmt enzymes (Meilinger et al. 2009; 
Berkyurek et al. 2014), thus maintaining DNA methylation. Another member of the Uhrf family, 
Uhrf2, which has similar domains to Uhrf1 (Bronner et al. 2007) has also been implicated in DNA 
methylation as it can bind hemimethylated DNA (Pichler et al. 2011). 
DNA can be either actively or passively demethylated. Until recently, the only form of 
demethylation was considered passive wherein lack of maintenance of DNA methylation in 
dividing cells causes the daughter cells to loss the 5mC mark. However, recent evidence has 
shown the presence of enzymes capable of converting the 5mC mark to 5-hydroxy methyl 
cytosine (5hmC) (Tahiliani et al. 2009; Ito et al. 2010) (Figure 2-3). These enzymes are termed 
as Ten-Eleven-Translocation (Tet) enzymes. The Tet family of enzymes has 3 members till date 
– Tet1, Tet2 and Tet3. The Tet enzymes function by oxidizing 5mC to 5hmC as an initial 
intermediate (Ito et al. 2011). The 5hmC mark can be further oxidized to 5-carboxyl cytosine 
(5CaC) and 5-formyl cytosine (5fC) (Ito et al. 2011) (Figure 2-3). The 5fC and 5caC mark can be 
reverted to an unmodified cytosine by Base Exchange Repair (BER) (He et al. 2011; Maiti and 
Drohat 2011). Interestingly, a recent study has elucidated that Uhrf1 can bind the 5hmC mark with 
equal affinity at 5mC (Frauer et al. 2011). 
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Fig. 2-3. Epigenetic modifications of cytosine residue in DNA. Reprinted by permission from 
Macmillan Publishers Ltd: Nature biotechnology (Song et al. 2012) copyright (2012). License no. 
4056700245047 
 
Cytosine can be modified from C to 5mC by methyltransferases such as Dnmt enzymes. 5mC 
can be converted to 5hmC, 5fC and 5caC by the Tet enzymes. The oxidation products of 5fC and 
5caC can be removed by TDG to generate an abasic site which is converted to a cytosine by BER 
(Base Exchange Repair). 5hmC can be converted to 5hmU by AID/APOBEC and 5caC can be 
converted to C by decorboxylation. The solid arrows indicate pathways which have been validated 
whereas the dotted arrows need yet to be confirmed. 
 
DNA methylation is a largely repressive mark wherein stretches of CpGs, identified as CpG 
islands, are methylated and subsequently the corresponding genes are transcriptionally silent 
(Deaton and Bird 2011). Methylated CpGs can be recognized by Methylated DNA binding domain 
proteins (MBDs) such as MecP2 (Fraga et al. 2003). Of the 28 million CpGs in the human genome, 
about 60-80% are methylated (Smith and Meissner 2013), including CpG islands and other 
regions. DNA methylation is extremely widespread and can occur both in promoters and gene 
bodies as well as in non-coding regions of the genome. Most methylated genes and elements in 
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the genome are static across development and into adulthood and across somatic tissues. From 
the 60-80% of CpG methylation (among all CpGs) only about 10% occurs at CpG islands which 
are mainly at the transcription start sites of either housekeeping genes or developmentally 
regulated genes (Deaton and Bird 2011). Mechanisms by which DNA methylation prevents 
transcriptional activation have been studied widely and are largely attributed to the activity of CpG 
binding proteins and histone deacytelases and histone methylases. There are some hypotheses 
that DNA methylation in promoters can prevent access for transcription factors due to the binding 
of MBDs (Bird 1992). This additional layer of epigenetic complexity allows certain genes to be 
expressed in specific tissues and not others.  
Compared to 5mC, the other DNA marks are much lower in abundance in the genome. Whole 
genome mapping of the mouse genome revealed the 5hmC is present in about 0.1% of all 
cytosine in mouse embryonic stem cells (ESC) (Yu et al. 2012). However, the highest abundance 
of 5hmC has been described to be in the mouse brain, about 0.4-0.7% of all cytosines (Szulwach 
et al. 2011; Song et al. 2011). In comparison, 5caC and 5fC are extremely rare with only about 
20ppm (parts per million) of all cytosines and 3 ppm of all cytosines respectively in mouse ESCs 
(Ito et al. 2011). Studies are still early in understanding the stability of these new DNA marks and 
their functions. However, there is indication that the 5hmC mark can correlate with transcriptional 
activation (Wu et al. 2011). 
There are two instances during development wherein the global static nature of DNA methylation 
is drastically erased. These are during early pre-implantation development and in the germ line. 
During early pre-implantation development, the hypermethylated sperm undergoes rapid loss of 
5mC (Santos et al. 2002). Interestingly, although majority of the genome is demethylated, certain 
transposable elements called Intracisternal A-Particles (IAP) are kept methylated (Lane et al. 
2003)  
The other instance wherein DNA methylation is massively erased is in primordial germ cells at 
about embryonic day E10-11. Genome-wide studies indicate that also in these cells, although 
methylation is almost completely erased, on IAPs and some other retroviral elements, methylation 
remains intact (Hackett and Surani 2013). 
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2.1.3 Role of Dnmts and Tets in ESCs, early development and NSCs 
To understand the importance of epigenetic regulators in stem cells and neurogenesis, most 
studies have employed loss-of-function studies. Both Dnmt1 and Uhrf1 are highly expressed by 
mouse ESCs (Bostick et al. 2007; Sharif et al. 2007). Dnmt3a is predominantly expressed in 
oocytes and early preimplantation embryos where it establishes DNA methylation at imprinting 
control regions in gametes (Kaneda et al. 2004; Kato et al. 2007). Dnmt3b is strongly expressed 
at the blastocyst stage (Watanabe et al. 2002).  
Complete knockout of Dnmt1 enzyme is embryonically lethal due to a massive loss of methylation 
(Li et al. 1992). Interestingly, loss of Uhrf1 causes a similar phenotype (Sharif et al. 2007). Deletion 
of Dnmt3b also causes embryonic lethality (Okano et al 1999). However, knockout of Dnmt3a is 
partially viable (Okano et al. 1999). Dnmt3L knockout mice are also partially viable (Bourc'his et 
al. 2001; Bourc'his and Bestor 2004) 
In contrast to the Dnmts and Uhrf1, the Tet enzymes are more dispensable in terms of embryonic 
lethality. Tet1 single knockout and Tet1/Tet2 double knockouts are viable with a slight 
developmental delay (Dawlaty et al. 2011; Dawlaty et al. 2013). Triple knockout of Tet1/Tet2/Tet3 
led to a significant loss of 5hmC and defects in ESC differentiation (Dawlaty et al. 2014). 
Conditional knockout of Dnmt enzymes have been generated and studied in neurogenic niches. 
Dnmt1 is expressed by cortical radial glia, adult neurons and adult neural stem cells (Hutnick et 
al. 2009; Feng et al. 2010; Noguchi et al. 2015). Deletion of Dnmt1 in the dorsal telencephalon at 
early embryonic stages resulted in severe neuronal death with an activation of the retroviral 
elements, IAPs (Fan et al. 2001; Hutnick et al. 2009). Interestingly, deletion of Dnmt1 in 
hippocampal neurons did not affect their numbers but synaptic plasticity was affected (Feng et al. 
2010). Loss of Dnmt1 in aNSCs of the hippocampus affected the production of new neurons 
(Noguchi et al. 2015).  
Dnmt3a is expressed by NSCs derived from ESCs and loss of function studies indicated defects 
in both proliferation and differentiation (Wu et al. 2010). Dnmt3b function in NSCs was studied by 
using Dnmt3b knockout ESCs and differentiating them into early neuroepithelial stages. In this 
study, Dnmt3b was found to be important for early neuroepithelial specification (Martins-Taylor et 
al. 2012). A comprehensive study of Dnmt3a expression and function was performed in postnatal 
neural stem cells (Wu et al. 2010). Dnmt3a was found to be highly expressed by postnatal NSCs 
of the SEZ and dentate gyrus and conditional deletion led to defects in neurogenesis. Moreover, 
                                                                                                                                                                     Introduction 
 
11 
 
Dnmt3a was found to occupy and methylate intergenic regions and gene bodies of several 
neurogenic genes (Wu et al. 2010).  
Besides Dnmts, many studies have investigated the role of proteins binding methylated DNA 
(MBDs) in the neurogenic niches. MBD1 knockout mice showed impaired neurogenesis in the 
adult (Zhao et al. 2003; Li et al. 2008). Another heavily studied protein is MeCP2 which is 
implicated in Rett’s syndrome. MeCP2 is most expressed in neurons and MeCP2 knockout mice 
exhibit defects in neuronal maturation but not in their numbers (Smrt et al. 2007). 
As 5hmC is most abundant in the brain, many studies have investigated the role of 5hmC and Tet 
proteins in neurogenesis. In the embryonic cortex, 5hmC is abundant in neurons and accumulates 
in gene bodies of neuronal genes (Hahn et al. 2013). Tet1 has very low expression in the 
embryonic cortex, with Tet2 and Tet3 being highly expressed by progenitors and neurons (Hahn 
et al. 2013). Acute knockdown of Tet2 and Tet3 in cortical radial glia resulted in accumulation of 
cell clusters in the cortex, suggesting aberrant neuronal migration (Hahn et al. 2013). Tet1 
knockout mice exhibited impaired hippocampal neurogenesis with some genes being 
hypermethylated  
In summary, loss of function studies of Dnmt and Tet protein suggest that these proteins play key 
cell-type and niche specific roles in regulating transcription and cell fate.  
 
2.1.4 Uhrf1 and Uhrf2 
Besides Dnmts and Tet enzymes, another protein has been described to play a key role in 
maintaining DNA methylation, Uhrf1. Uhrf1 is a multi-functional protein with several domains. As 
mentioned previously, Uhrf1 can bind hemi-methylated DNA with its SRA domain. Uhrf1 
possesses a RING finger domain, linked to histone and protein ubiquitination and turnover 
(Citterio et al. 2004; Liu et al. 2013; Nishiyama et al. 2013; Qin et al. 2015). Furthermore, Uhrf1 
has also been described to establish and reorganize heterochromatin (Papait et al. 2008; De Vos 
et al. 2014). Uhrf1 also possesses a tandem tudor domain (TTD) which can bind the H3K9me3 
mark (Karagianni et al. 2008).  Besides Dnmts, Uhrf1 can also interact with histone modifiying 
enzymes such as HDAC1, Tip60 and G9a (Unoki et al. 2004; Achour et al. 2009; Kim et al. 2009) 
(Figure 2-4). These data suggest Uhrf1 to be an important link between DNA and histone 
methylation. Indeed, deletion of the RING finger domain which binds methylated histones, can 
lead to defects in DNA methylation in mouse ESCs (Nishiyama et al. 2013). 
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Fig.2-4 The different domains of Uhrf1 and its interaction partners. Modified from (Alhosin et 
al. 2011) (Open Access article distributed under the terms of the Creative Commons Attribution 
License) 
Schematic of the domains of Uhrf1 – SRA interacting with DNA and Dnmt1, RING, TTD and PHD 
domain which binds histones. Uhrf1 can interact with the proteins HDAC1, G9a and Tip60. 
 
 
Besides ESCs, Uhrf1 is expressed in skin stem cells during proliferation and downregulated upon 
differentiation (Sharif et al. 2007; Sen et al. 2010). It has also been described to play a crucial role 
in regulatory T cell differentiation, whereby loss of Uhrf1 in these cells led to defects in proliferation 
and differentiation (Obata et al. 2014). Many studies have implicated a role for Uhrf1 in cancer 
formation and progression (Hervouet et al. 2010; Tien et al. 2011; Babbio et al. 2012; Pacaud et 
al. 2014). Moreover, Uhrf1 has been shown to negatively regulate the Pml protein in human 
endothelial cells (Guan et al. 2013). Uhrf1 has been recently been shown to be important in 
maintaining the balance between self-renewal and differentiation of hematopoietic stem cells by 
regulating DNA methylation of key stem cell genes (Zhao et al. 2016).  
Uhrf2 is also expressed by mouse ESCs (Pichler et al. 2011). However, in contrast to Uhrf1, Uhrf2 
is expressed highly during ESC differentiation (Pichler et al. 2011). Thus, Uhrf1 and Uhrf2 seem 
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to exhibit contrasting modes of expression. Genetic knockouts of Uhrf2 has not been studied yet 
and thus its exact function is largely unknown. 
Although many studies have examined the role of Dnmts and Tet enzymes in neurogenesis, the 
function of Uhrf1 has not been examined in NSCs.  
 
2.2 Transposable elements 
One group of genomic loci wherein DNA methylation has been described to play a key role in 
regulating their epigenomic landscape and transcription, is that of ERVs. ERVs form a class of 
transposable elements (TEs) which are sequences of DNA that can jump around the genome. 
However, ERVs form a part of the retrotransposon family which can multiply prior to transposition 
(Sharif et al. 2013). Nearly half of the genome is comprised of TEs and ERVs are about 5% of the 
mouse and human genome (Kassiotis 2014) (Figure 2-5). Other types of retrotransposons are 
more abundant such as LINE-1 elements (19% of genome) and SINE elements (8% of genome) 
(Kassiotis 2014). ERVs have arisen from germline integration of retroviruses which have infected 
mammals through evolution (Dewannieux and Heidmann 2013). These ERVs largely resemble 
retroviruses, comprising of gag, pro, pol and env genes flanked by long-terminal repeats or LTRs. 
The LTR region often act as promoters. There are many different types of ERVs in both the mouse 
and human genome. The mouse genome has a specific ERV known as IAP (Figure 2-5) which is 
present as about 1000 copies in the genome (Barbot et al. 2002). The IAP elements themselves 
comprise of several subtypes, largely based on their structure, as some of them are heavily 
truncated (Sharif et al 2013).  
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Fig. 2-5 Transposable elements in the genome. Reprinted by permission from Macmillan 
Publishers Ltd: Nature Reviews Genetics (Cordaux and Batzer 2009) copyright (2009). License 
no. 4056710870507 
 
Schematic showing the percentage of different types of transposable elements in the genome. 
The sequence of LINE-1 elements with its open reading frames (orf) and the sequences of ERVs 
is depicted. Note that IAP elements form a part of ERVs which contain gag, pro, pol and env 
genes with flanked LTRs.  
 
 
During development, in preimplantation blastocysts and in primordial germ cells, there is a 
genome- wide erasure of 5mC which occurs (Messerschmidt et al. 2014). During this time, many 
regions in the genome have been shown to resist the loss of 5mC, such as the IAP subclass of 
ERVs (Guibert et al. 2012; Hackett and Surani 2013). However, interestingly, loss of 5mC in 
somatic cells at later stages of development, does indeed cause IAP activation. Therefore, 
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depending on the cell-type and developmental time, IAP transcription can be under the control of 
levels of DNA methylation.  
The impact of retrotransposons on mammalian cells has been described to be both beneficial and 
harmful. Studies have suggested that LINE-1 elements can contribute to the evolution of complex 
brains and the generation of neuronal diversity (Muotri et al. 2005; Singer et al. 2010) . However, 
there are also multiple reports which have linked overexpression of retrotransposons to cell death, 
genome instability, stress response and cancer (Morrish et al. 2002; Belgnaoui et al. 2006; 
Sinibaldi-Vallebona et al. 2006; Pasquarella et al. 2016).  
Regulation of retrotransposons in neural development is still in its infancy and data from the LINE-
1 studies suggest that it may be of importance in this niche. 
 
2.3 Embryonic forebrain 
 
2.3.1 Development of the embryonic forebrain 
Neurogenesis is a dynamic process which requires tight transcriptional control in a spatial and 
temporal manner. The main events occurring during neurogenesis are neural stem and progenitor 
proliferation and neuronal differentiation and maturation. Each of these steps are regulated by 
several key coding genes and non-coding elements in the genome.  
Neurogenesis is widespread during embryonic development, occurring in several regions of the 
brain. In the embryonic cerebral cortex, neurogenesis commences at about E10. Prior to this 
stages, the developing cortex is derived from the neural tube. The neural tube is initially divided 
into the prosencephalon (which forms the telencephalon or anterior embryonic forebrain and 
diencephalon or posterior forebrain), the mesencephalon (midbrain), the rombhencephalon or 
hindbrain (develops into pons, cerebellum and medulla oblongata) and the spinal cord.  
At about E8.5, the telencephalic primordium is specified by the induction of the transcription factor 
Foxg1 (Tao and Lai 1992; Shimamura and Rubenstein 1997). Following this, the telencephalon 
is subdivided into two specific domains - the ventral and dorsal telencephalon. The specific 
domains of the telencephalon are established by signaling gradients which control the expression 
of specific transcription factors in each domain. The ventral telencephalon is further subdivided 
into the neocortex which lies in the anterior lateral region and the posterior medial region which 
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develops in the hippocampus, cortical hem and the choroid plexus. The ventral telencephalon is 
also divided into the medial region termed the medial ganglionic eminence (MGE) and the 
posterior lateral regions are termed lateral ganglionic eminence (LGE) and caudal ganglionic 
eminence (CGE).  
The telencephalon is composed of the lateral ventricles which are lined by germinal zones. The 
ventricle itself is composed of cerebral-spinal fluid produced by the choroid plexus (a network of 
ependymal cells). 
 
2.3.2 Overview of embryonic neurogenesis 
At about E9-E10, the process of neurogenesis commences in the telencephalon. Neurogenesis 
is the process by which neurons are generated from neural stem and progenitor cells. The main 
difference between the dorsal and ventral region of the telencephalon lies in the type of neurons 
they produce. The dorsal telencephalon primarily produces glutamatergic neurons whereas the 
ventral telencephalon generates mainly GABAergic neurons. Neurons generated in the neocortex 
migrate radially and remain in the neocortical domain. However, neurons generated in the 
ganglionic eminences can migrate tangentially to different regions (Figure 2-6A). The LGE derived 
neurons migrate primarily to the olfactory bulb and amygdala. The MGE and CGE derived 
neurons migrate tangentially to the neocortex and integrate into the existing neuronal network 
(Marin and Rubenstein 2001) (Figure 2-6A). The different regions of the telencephalon and their 
molecular markers are depicted in Figure 2-6B. These molecular markers are specific 
transcription factors which instruct certain cell fates in a spatial and temporal manner. The sharp 
border between the dorsal and ventral telencephalon is primarily setup by the transcription factors 
Pax6 and Gsx2 (Figure 2-6B). In fact, in Pax6 knockout embryos, the ventral part of the neocortex 
become specified as the dorsal LGE and in the Gsh2 knockout embryos, the dorsal LGE is 
specified into the ventral cortex (Corbin et al. 2000; Stoykova et al. 2000; Toresson et al. 2000; 
Yun et al. 2001). In the mouse telencephalon, neurogenesis occurs until about E18 with the 
process peaking at E14. Following neurogenesis, the generation of glia, a process known as 
gliogenesis, occurs from the end of development and into postnatal stages.  
Much of our understanding of neurogenesis in the telencephalon is derived from studies in the 
neocortex, with the ganglionic eminence exhibiting some differing and some common features 
(Pilz et al. 2013). 
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Fig.2-6 Regions of the telencephalon 
Adapted by permission from Macmillan Publishers Ltd: Neuron (Ross et al. 2003) copyright 
(2003). License no. 4050741125950. (A) and (Nat et al. 2013) (open access under CC BY 3.0 
license) (B) 
A. Coronal section of the telencephalon depicting the dorsal and ventral regions and their 
respective types of neurons. 
B. Coronal section of the telencephalon depicting the specific transcription factors in each domain. 
Emx1/2 and Pax6 are dorsally expressed. Nkx2.1 is specific to the MGE and Gsh2 is in the LGE 
and MGE. 
 
2.3.3 Cell types in the embryonic neocortex 
The neuroepithelium of the telencephalon at the onset of neurogenesis is composed of 
neuroepithelial cells termed radial glia. These cells act as neural stem cells - capable of self-
renewal and multipotency, generating both neurons and glia. Radial glia are situated in the 
ventricular zone (VZ) and maintain contact to the inner ventricular surface and the outer pial 
surface via apical and basal process. However, their cell body is stationed in the ventricular zone, 
which is the region adjacent to the ventricle (Figure 2-7). At early neurogenic stages, until about 
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E11, the radial glia mainly undergo symmetric self-renewal cell divisions in order to expand their 
pool (Gotz and Huttner 2005). Following this time, they start generating a population of transit-
amplifying progenitors termed basal or intermediate progenitors via asymmetric divisions 
(Haubensak et al. 2004; Noctor et al. 2004; Noctor et al. 2007).  These basal progenitors do not 
exhibit apical-basal polarity and are multipolar in nature. In addition to apically located radial glia, 
another type of cell termed as subapical progenitors has been recently reported (Pilz et al. 2013). 
Moreover, another type of progenitor has been identified termed as basal radial glia (Reillo et al. 
2011; Wang et al. 2011; Florio and Huttner 2014) which are cells harboring radial glia features 
but with only a basal process in contact with the pial surface (Figure 2-7). Moreover, they are 
situated more basally outside the ventricular zone.  
Generation of basal progenitors leads to the appearance of an additional zone in the neocortex 
(Figure 2-7) termed as the subventricular zone (SVZ) wherein most of these progenitors reside. 
Basal progenitors mainly undergo symmetric divisions to either self-renew or generate neurons 
(Haubensak et al. 2004; Miyata et al. 2004; Noctor et al. 2004; Noctor et al. 2007). Radial glia and 
basal progenitors can be differentiated by the expression of certain transcription factors. Radial 
glia express Pax6 whereas basal progenitors express Tbr2. Basal progenitors can also self-renew 
and undergo terminal divisions to generate neurons at different periods of neurogenesis. These 
neurons migrate through the intermediate zone (IZ) and form the developing cortical plate (CP). 
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Fig.2-7 Cell types in the embryonic cortex. Modified from (Gomez-Lopez et al. 2014) (Open 
Access article distributed under the terms of the Creative Commons Attribution License) 
At early neuroepithelial stages, the neuroepithelial cells divide to generate radial glia (purple cells 
with process). The radial glia divide both symmetrically to self-renew and asymmetrically to 
generate basal progenitors and neurons. Radial glia can generate neurons both by direct 
neurogenesis (first purple radial glia generating neurons, depicted in orange), as well as by 
indirect neurogenesis (via basal progenitors depicted in green). Neurons migrate into the cortical 
plate and reside per their birthdate and layer. The mammalian cortex also contains basal or outer 
radial glia (purple cells with only basal process) and subapical radial glia (not shown). 
LV – lateral ventricle; VZ – ventricular zone; SVZ – subventricular zone; RG – radial glia; BP – 
basal progenitor; oRG – outer radial glia 
 
 
2.3.4 Cortical layering and postnatal terminal neuron differentiation 
Newly generated neurons in the neocortex migrate radially to form the 6-layered cortex in an 
inside-out manner wherein the early born neurons are situated close to the ventricle and the late 
born neurons are close to the pial surface (Figure 2-8). The first-born neurons, termed Cajal-
Retzius cells, which comprise of layer I of the cortex, are generated at E11. Layer VI neurons are 
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generated following these neurons at about E13-E14 and express the transcription factor Tbr1. 
Following Layer VI, layer V neurons are produced which are mainly labelled by Ctip2. Layer IV 
neurons are labelled by Rorb/Satb2, layer II/III neurons by Cux1.  
During the first few weeks of postnatal development, the neurons in the cerebral cortex undergo 
terminal neuronal differentiation. Most of the neurons born in the cerebral cortex are projection 
neurons. However, it is important to note here that GABAergic neurons migrate into the cortex 
from the GE. Projection neurons can either form connections with neurons of the contralateral 
hemisphere via the callosum (cortico-cortico projection neurons) or anterior commissure (Greig 
et al. 2013) or form corticofugal projections which project away from the cortex. The corticofugal 
connections are either thalamocortical (to the thalamus) or other subcerebral projections (Greig 
et al. 2013). 
Once the projection neurons in the embryonic cortex migrate to the correct layer, they initiate 
axon and dendritic growth. These processes are essential to further build synapses which enable 
specific connections between neurons. In early postnatal stages, between P1 to P8, there is 
additional axon growth and guidance (Lewis et al. 2013). From P8 to P21 axon branching and 
synapse formation occurs (Lewis et al. 2013). Defects in any of these processes can lead to 
neurodevelopmental disorders such as autism spectrum disorders, epilepsy and mental 
retardation (Zoghbi and Bear 2012).  
Another important process which occurs in postnatal neurons is the downregulation of cell cycle 
proteins. Postmitotic neurons still express members of the Retinoblastoma family of proteins, E2F 
transcription factors, Cyclin-dependent kinases and inhibitors after terminal neuron differentiation 
(Yoshikawa 2000). It has been hypothesized that these cell cycle proteins are relevant for neuron 
survival and maintenance of differentiation (Cicero and Herrup 2005; Liu et al. 2005; Kurita et al. 
2006; Nguyen et al. 2006; Hasegawa and Yoshikawa 2008). Regulation of these cell-cycle 
proteins seems critical as misregulation could lead to neuronal death in adult neurons (Herrup 
and Yang 2007). 
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Figure 2-8 Chronological generation of different types of cortical neurons in an inside-out 
manner. Adapted by permission from Macmillan Publishers Ltd: Nature reviews neuroscience 
(Molyneaux et al. 2007) copyright (2007). License no. 4052120920271. 
 
The early born neurons form the preplate which later splits into the superficial marginal zone and 
deep subplate. The different layers of the cortical plate are formed between these two layers 
during the main period of neurogenesis from E12-E16.  
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2.4 Adult neurogenesis and gliogenesis 
 
2.4.1 Adult neurogenic niches and cell types 
In the postnatal and adult brain, neurogenesis occurs only in certain specific niches, namely the 
subependymal zone (SEZ) of the lateral ventricle and the dentate gyrus (DG) of the hippocampus 
(Kriegstein and Alvarez-Buylla 2009) (Figure 2-9A). The early evidence for these niches were 
from first from neurosphere experiments showing the ability of aNSCs to self-renew and be 
multipotent (Reynolds and Weiss 1992). Following this, transplantation experiments were 
performed wherein SEZ cells were grafted either homotypically (i.e. SEZ from one mouse into 
SEZ of another mouse) (Lois and Alvarez-Buylla 1994) or heterotypically (SEZ of one mouse into 
other regions of the brain of another mouse) into the striatum wherein neurogenesis does not 
occur (Herrera et al. 1999). In the homotypic situation, the grafted cells could integrate and 
differentiate, but not in the heterotypic condition 
The source of adult neural stem cells was previously shown to be radial glia (Merkle et al. 2004). 
Moreover, recent studies have indicated that LGE progenitors could be ancestors of adult neural 
stem cells (Furutachi et al. 2013). Adult neural stem cells (aNSCs) exhibit many radial glial 
features, sharing common molecular markers. Adult neural stem cells in the SEZ are relatively 
quiescent but can divide to generate actively proliferating transit-amplifying progenitors (TAP) 
(Doetsch et al. 1999). These TAPs generate immature neuroblasts which migrate tangentially to 
the olfactory bulb from the SEZ and differentiate into interneurons (Lois and Alvarez-Buylla 1994; 
Belluzzi et al. 2003; Carleton et al. 2003), which integrate into existing circuitry (Figure 2-9B).  
In the dentate gyrus, aNSCs also possess radial glial properties (Seri et al. 2001; Fukuda et al. 
2003; Garcia et al. 2004). These aNSCs generate intermediate progenitor cells which in turn give 
rise to neurons which migrate radially and reside in the hippocampus (Seri et al. 2004) (Figure 2-
9C). Neurons in the dentate gyrus are glutamatergic projection neurons and play important roles 
in learning and memory. 
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Fig.2-9. Adult neurogenic niches.  
Adapted by permission, (Ninkovic and Gotz 2013) License no. 4050750571282 (A) and adapted 
by permission from Macmillan Publishers Ltd: Nature reviews neuroscience (Yao et al. 2016) 
copyright (2016). License no. 4050750893071 (B,C) 
A. Scheme showing tranverse section of the adult brain. The regions in red indicate the 
neurogenic niches in the SEZ and DG of the hipoocampus. The scheme shows the restriction of 
neurogenesis to these regions as compared the widespread gliogenesis (green dots are cells) 
occurring throughout the parenchyma. 
B. Scheme showing the cell types and the process of neurogenesis in the SEZ. Radial glia like 
NSCs get activated (blue cells, left group of cells) and generate IPCs or TAPs (purple cells, middle 
group of cells) which in turn generate neuroblasts (green cells, right panel). The neuroblasts 
migrate along the rostral migratory stream to the olfactory bulb. 
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C. Scheme of the cell types and the process of neurogenesis in the SGZ. Radial glia like NSCs 
get activated (blue cells) and generate IPCs or TAPs (purple cells) which in turn generate 
neuroblasts (green cells). The neuroblasts mature into neurons which migrate radially and remain 
in the hippocampus. The NSCs also generate parenchymal astrocytes (in red). 
 
2.4.2 Gliogenesis 
As mentioned earlier, neurogenesis subsides towards the end of embryonic development, 
allowing gliogenesis to commence. Glia are mainly generated either by precursor cells or by 
terminal differentiation of radial glia into differentiated glia. There are two main types of glial cells 
– astrocytes and oligodendrocytes. Astrocytes are mainly generated from radial glia, possibly as 
a direct conversion (Noctor et al. 2008; Kriegstein and Alvarez-Buylla 2009) (Figure 2-10A). 
Astrocytes can range from about 20-40% of all glia and perform several functions from providing 
biochemical support to endothelial cells of the blood-brain barrier, acting as a source of nutrients 
and other extracellular factors to neurons and playing roles in brain injury and repair. Most 
astrocytes have a characteristic morphology of short, highly branched tertiary processes.  
The other type of glia, namely oligodendrocytes, are born at early embryonic stages as well as 
later stages. Oligodendrocytes provide trophic support to neurons (Bradl et al. 2010). 
Furthermore, they produce myelin sheaths which are important for nerve impulses and reducing 
ion leakage. There are three known waves of oligodendrocyte production in the forebrain. The 
first wave occurs at E16 wherein progenitors in the MGE generate a wave of oligodendrocytes 
which migrate towards the cortex (Pringle and Richardson 1993; Spassky et al. 1998; Tekki-
Kessaris et al. 2001). Following this wave, another group of oligodendrocytes appear from the 
LGE (Kessaris et al. 2006). Finally, at E18, a third wave of oligodendrocytes are locally born from 
cortical progenitors (Kessaris et al. 2006) (Figure 2-10B). It is interesting to note that at postnatal 
stages, most of the early born oligodendrocytes disappear and only the late born oligodendrocytes 
remain in the cerebral cortex (Kessaris et al. 2006). 
Some studies have indicated that a subpopulation of OPCs are also generated postnatally 
(Levison and Goldman 1993; Nait-Oumesmar et al. 1999; Menn et al. 2006; Aguirre et al. 2007). 
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Fig.2-10. Gliogenesis in the embryonic forebrain 
Reprinted with permission from Elsevier (Barry et al. 2014) License no. 4050751151722 (A) and 
adapted by permission from Macmillan Publishers Ltd: Nature reviews neuroscience 
(Richardson et al. 2006) copyright (2006) License no. 4057890885482 (B). 
A. Schematic showing the generation of astrocytes and oligodendrocytes from embryonic radial 
glia and adult neural stem cells, from radial glia at the end of neurogenesis.  
B. Schematic of a coronal section of the embryonic brain indicating the modes of OPC generation. 
OPC1 (Red arrows, 1) indicates the first wave at E16 from the MGE. OPC2 (blue arrows, 2) is 
the second wave following the first wave from the LGE and MGE and the third wave (green 
arrows, 3) occurs around E18 from cortical radial glia. 
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3. Aims of my thesis 
 
Conditional deletion of Uhrf1 in the dorsal telencephalon (using Emx1-Cre) (Cappello et al. 2006; 
Iwasato et al. 2000) led to decreased cerebral cortical thickness in 1-month old mice (Bayam. 
2014). Moreover, loss of Uhrf1 in adult neurogenic niches led to defects in neuronal differentiation 
(Bayam. 2014). These data have implicated an important role for Uhrf1 in regulating appropriate 
cerebral cortex neurons numbers and adult neurogenesis. Defects in progenitor proliferation were 
not observed at embryonic stages (analysed by pH3 and Pax6). However, an increase in cell 
death was observed with TUNEL mid embryonic stages. In contrast, conditional deletion of Uhrf1 
in the adult SEZ and dentate gyrus (using GlastCre ERT2; Uhrf1 flox; CAG) (Mori et al. 2006) 
resulted in a decrease in transit-amplifying progenitors (TAPs) and neuroblasts, indicating 
differing roles for Uhrf1 in embryonic and adult neurogenesis. 
Based on these findings, the main of my project was in unravelling the molecular mechanism of 
Uhrf1 in neural stem cells. Additionally, we made some preliminary attempts to test if these 
mechanisms could act during adulthood as well. In particular, we first studied the cellular 
phenotypes observed during conditional loss of Uhrf1 in neural stem cells of the developing 
cerebral cortex. Following this, we dissected the molecular role of Uhrf1 in these cells, analyzing 
transcriptional and epigenetic processes. Finally, we examined some of the phenotypes observed 
in the conditional knockout of Uhrf1 in adult neurogenic niches, with emphasis on its molecular 
function. 
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4. Results 
4.1 Uhrf1 expression from embryonic to adult stages 
To characterize Uhrf1 expression, we performed Uhrf1 qRT-PCR in E14 NSCs (isolated by FACS 
with Prominin 1 antibody), E14 neurons (isolated by FACS by PSA-NCAM antibody), adult 
subependymal zone and adult grey and white cortical matter (Figure 4-1A). Indeed, we could 
observe about 40-fold higher Uhrf1 mRNA in E14 NSCs as compared to neurons. Moreover, 
Uhrf1 mRNA was barely detectable in adult cortical grey matter (Figure 4-1A). We also performed 
Uhrf1 immunostainings at postnatal day 5 (P5). We observed only few cells in the cortex to 
express Uhrf1 (Figure 4-1B). These cells did not colocalize with NeuN, a neuronal marker (Figure 
4-1C), however, some did co-label with Ki67, indicating some of the Uhrf1+ve cells are 
proliferating (Figure 4-1D). Thus, our data in conjunction with the previous study, shows that Uhrf1 
is primarily expressed in NSCs and progenitors and is largely absent in neurons of the embryo 
and adult cerebral cortex.  
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Fig.4-1 Uhrf1 expression in embryonic and adult neurogenic niches 
A. qRT-PCR for Uhrf1 showing high expression in NSCs and almost absence in neurons. E14 
cortical tissue was dissociated to isolate NSCs by Prominin 1 and neurons by PSA-NCAM by 
FACS. Grey and white matter and SEZ tissue was isolated from 2-month old mice. qRT-PCR was 
performed for Uhrf1 in the above populations using Gapdh as the housekeeping gene.         * 
indicates significance with p-values 0.009 and 0.00005 respectively. Error bars indicate standard 
error of mean. n=3. 
B-D. Confocal images of coronal sections of P5 cerebral cortex immunostained for Uhrf1 (B), 
Uhrf1 and NeuN (C) and Uhrf1 and Ki67 (D) showing the absence of Uhrf1 in neurons. Scale bar 
= 50µm.  
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4.2 Characterization of Uhrf1 cKO cellular phenotype 
 
4.2.1 Comparable numbers of neurons and glia at E16 
A conditional knockout of Uhrf1 was generated specifically in the developing cerebral cortex using 
the Emx1-Cre mouse line (Iwasato et al. 2000; Ramesh et al. 2016) which recombines specifically 
in the dorsal telencephalon, deleting Uhrf1 in this region. Emx1cre+/- Uhrf1f/f mice (hereby referred 
to as cKO) is compared to Emx1cre+/- Uhrf1f/- mice (hereby referred to as controls). We performed 
Uhrf1 immunostaining at E12 and could observe a loss of Uhrf1 protein in the cKO (Figure 4-
2A,B), specifically in the dorsal telencephalon and not in the LGE where Uhrf1 was not deleted 
(Figure 4-2B). We further investigated the cellular phenotype by assessing proliferation of 
progenitors and numbers of neurons at embryonic stages. We assessed proliferation with Ki67 
immunostaining at E16 in cKO cortices and controls. We could not observe a significant difference 
in the cKO compared to the control (Figure 4-2C,D). However, we did detect an increase in non-
apical Ki67 positive cells in the cKO. We performed Tuj1 (to label all neurons) and Tbr1 (label 
neurons in the cortical plate) immunostaining at E16 and did not detect any evidence of premature 
differentiation (Figure 4-2E-H). Moreover, the numbers of Tbr1+ve neurons were unchanged 
(Figure 4-2I). 
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Fig. 4-2 Comparable proliferation and neuron numbers at E16 in the cKO 
A-B. Confocal images of coronal sections at E12 of cerebral cortex of controls (A) and cKO (B) 
immunostained for Uhrf1 (A,B). Note the loss of Uhrf1 in cKO in the cerebral cortex wherein it was 
deleted as opposed to the LGE where Cre recombination did not occur (B).  
C-H. Confocal images of coronal sections of the cerebral cortex at E16 of controls (C,E,G) and 
cKO (D,F,H)  immunostained for Ki67 (C,D), Tuj1 (E,F) and Tbr1 (G,H).  
I. Quantifications of Tbr1+ve cells per area of sections from (G) and (H). Error bars indicate 
standard error of mean. N=4. 
Scale bar = 50µm. Abbreviations: CP – cortical plate; VZ – ventricular zone; SVZ – subventricular 
zone 
 
 
It has been previously reported that cell death can lead to activation of glial cells (Robel et al. 
2011). Thus, we investigated if glial cells were altered in the Uhrf1 cKO compared to controls. We 
performed immunostaining for Gfap at E16 and could not observe any activation in the cKO 
(Figure 4-3A,B). Furthermore, microglial cells, labelled by Iba1 immunostaining at E16, appeared 
comparable in number and morphology in controls and cKO (Figure 4-3C,D). However, in 1 month 
old mice we did observe Gfap activation in the cKO, which is probably a result of reactive gliosis 
due to neuronal death (Figure 4-3E,F). 
These results suggest that neurons and glia are generated in an appropriate manner in the cKO 
and control during embryonic stages. 
 
 
 
 
 
 
 
Results 
 
32 
 
 
 
Fig.4-3 Absence of glial cell activation in E16 cKO cortices with reactive gliosis at later 
stages 
A-D. Confocal images of coronal sections of the cerebral cortex at E16 of controls (A,C) and cKO 
(B,D) immunostained for Gfap (A,B) to label astrocytes and Iba1 (C,D) to label microglia. Note 
the absence of Gfap staining in both cKO and controls and comparable Iba1 staining in cKO and 
control. 
E,F. Confocal images of coronal sections of the cerebral cortex at P27 of controls (E) and cKO 
(F) immunostained for Gfap. Note the reactive gliosis at in 1-month old cKO cerebral cortex. Scale 
bar = 50µm 
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4.2.2 Cortical layering at embryonic and postnatal stages appeared normal in the cKO 
As generation of neurons was not impaired in the cKO, we next sought to determine if the neuronal 
layers of the cortex were specified in the appropriate manner. We performed immunostaining for 
Ctip2 to label upper layer neurons and Tbr1 to label lower layer neurons at E18 and could not 
detect any abnormalities in the cKO as compared to the control (Figure 4-4A,B). Furthermore, we 
also performed Ctip2 immunostaining at P2 and observed analogous staining in controls and cKO 
(Figure 4-4C-D). These results suggest that neurons are generated and specified correctly into 
the layers of the cerebral cortex of Uhrf1 cKO animals. 
 
                   
 
Fig.4-4 Upper layer and lower neuronal identity is maintained in Uhrf1 cKO cortices 
A-D. Confocal images of coronal sections of cerebral cortex of controls (A,C) and cKO (B,D) 
immunostained for Ctip2 and Tbr1 at E18 (A,B) and Ctip2 at P2 (C,D)  
Note that the cortical layers in controls and cKO appear intact in all stages. Scale bar = 50µm. 
Abbreviations: CP – cortical plate; LL – lower layers; UL – upper layers 
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4.2.3 Cell death peaks in the postnatal Uhrf1 cKO  
As mentioned previously, conditional knockout of Uhrf1 in the cerebral cortex exhibited cell death 
in embryonic stages. We sought to determine the onset of cell death by performing TUNEL 
staining as early as E12 (Figure 4-5A,B). We observed significantly higher TUNEL positive cells 
at E12, with about 4-fold higher in the cKO cortices (Figure 4-5C). Thus, the onset of cell death 
was observed at E12, at similar levels to later embryonic stages (Ramesh,Bayam et al. 2016).  
 
 
Fig.4-5 Onset of cell death was observed to be at E12 in cKO 
A-C. Confocal images of coronal sections of cerebral cortex at E12 of controls (A) and cKO (B) 
immunostained for TUNEL (A,B). Increase in TUNEL+ve cells was observed in the cKO 
compared to control. 
C. Quantifications of TUNEL+ve cells per area from A,B indicating 4-fold higher in the cKO. * 
indicates significance with Mann-Whitney test with p-value = 0.03, n=4.  Error bars indicate 
standard error of mean. Scale bar = 50µm. 
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Although cell death was observed from early embryonic stages, a reduction in cortical thickness 
was not detected until P7 (Figure 4-6A,B). We sought to determine the peak of cell death, by 
analyzing postnatal stages. We performed TUNEL analysis at P2 and P7 and observed up to 11-
fold higher cell death in P2 cKO (Figure 4-6C,D,G) as opposed to 6-fold higher at P7 (Figure 4-
6E,F,G). Thus, we could detect higher levels of TUNEL positive cells at early postnatal stages 
leading to a discernible reduction in cortical tissue at P7.  
In summary, deletion of Uhrf1 in embryonic neural stem cells showed no cell fate change or 
changes in proliferation and differentiation. The significant phenotype was an increase in cell 
death beginning at embryonic stages and escalating at postnatal timepoints. 
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Fig.4-6 Cell death peaks at postnatal day 2 in the cKO cortex 
A,B. Confocal images of coronal sections of cerebral cortex of P7 control (A) and cKO (B) stained 
with DAPI to indicate a reduction in cortical thickness in the cKO. 
C,D,E,F. Confocal images of coronal section of cerebral cortex of controls (C,F) and cKO (D,G) 
stained with the TUNEL kit at P2 (C,D) and P7 (F,G), indicating increased number of TUNEL+ve 
cells in the cKO. 
G. Quantifications of fold change of TUNEL+ve cells per area in P2 and P7 sections from C,D,E,F 
showing a significant increase in the cKO. * indicates significance with Mann-Whitney test with p-
value = 0.01, n=4 for P2 and N=2 for P7. Error bars indicate standard error of mean. Scale bar = 
50µm 
 
 
4.3. Transcriptional profiling of Uhrf1 cKO 
4.3.1 Activation of cellular stress genes at E16 and P5 Uhrf1 cKO 
To understand the underlying molecular mechanisms contributing to the observed cell phenotype 
in Uhrf1 cKO, we performed transcriptional profiling to uncover deregulated genes. Firstly, we 
focused on the region wherein Uhrf1 is expressed and thus dissected the germinal zones (GZ) of 
Uhrf1 cKO and controls and performed RNAseq (Figure 4-7A). We observed 68 upregulated 
genes and 30 downregulated genes (Fold change > 2 and p-value < 0.05) (Figure 4-7B, Table 1). 
Of these, 52 genes were derepressed (Table 1, highlighted in red). We defined a derepressed 
gene to have < 0.1 RPKM value in the control and > 2 fold change upregulation in the cKO.  
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Fig.4-7 Transcriptional profiling in E16 germinal zones in cKO and controls 
A.Schematic drawing showing microdissection of germinal zones (GZ) at E16 for the RNaseq. 
Blue dotted line indicates dissection cut. The tissue below the dotted line in the cortex was used 
for the RNAseq as Uhrf1 is expressed in this region. 
B. Expression plot of differentially regulated genes in the cKO compared to the control at E16 in 
the germinal zones. Red dots indicate upregulated genes, black dots indicate genes not changed 
in expression and blue dots indicate downregulated genes in the cKO. Fold change > 2 and p 
value < 0.05. X-axis and Y-axis values are FPKM (Fragments per million bases) from 100bp 
paired end RNAseq. 
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Table 1. Table of upregulated and down regulated genes in E16 germinal zones 
Table depicting upregulated and downregulated genes from Fig.4-7B at E16 in the germinal 
zones. Red indicates derepressed genes. 
 
Downregulated genesUpregulated genes
Table 1 – E16 cortex germinal zones RNAseq
Gene name FC Gene name FC Gene name FC
Serpinb1c 29.20 Nxf3 3.95 Apol7d 0.17
Ccrn4l 25.01 Xlr4b 3.94 Rsg1 0.24
Xlr3c 20.73 Pidd1 3.78 Gm2109 0.24
4930550L24Rik 20.52 Tex13 3.70 5830454E08Rik 0.29
Mnd1 15.81 Slfn4 3.69 Nnmt 0.29
4930500J02Rik 12.58 Gm773 3.67 Bcl2l10 0.30
Cdh19 10.97 Mtfp1 3.52 Kcnv1 0.32
Mia 10.84 Cd53 3.48 Cd79b 0.34
Rhox5 10.51 Ddr2 3.46 Hat1 0.34
Uba1y 9.97 Tuba3b 3.44 4930447C04Rik 0.35
Ccdc163 7.32 Dnajc6 3.36 Arhgap29 0.35
Col6a5 6.69 Nrtn 3.36 Pnliprp1 0.36
Sectm1a 6.65 Ly86 3.33 Bend6 0.36
E330017A01Rik 6.60 Klrb1b 3.20 Rorb 0.37
Rnf183 6.54 Slc15a2 3.12 Rgs8 0.39
Rpph1 6.39 Cdkl4 3.11 Gap43 0.40
Ccnb1ip1 5.92 Nkx2-3 3.08 Arpp21 0.42
Sohlh2 5.76 Slc25a18 2.93 Amer3 0.42
Ulbp1 5.61 Asns 2.90 Atpif1 0.43
Gfap 5.52 Fmo1 2.82 Csmd3 0.43
Mnd1-ps 5.32 Mbl2 2.82 Apoa1 0.43
Hamp2 5.06 Cacng1 2.75 Syn3 0.44
Crabp2 5.02 Batf3 2.68 B3galt2 0.44
Xlr4c 4.95 Trib3 2.66 Nfe2l3 0.46
Mgl2 4.61 Tmc3 2.65 Tceal8 0.47
Xlr4a 4.54 Hsd17b12 2.63 Lrp1b 0.48
Apoh 4.44 Ext2 2.62 Insig1 0.48
Tex101 4.31 Ptafr 2.62 Scn1a 0.49
Syce1 4.29 Ccnd1 2.46 Cat 0.49
Pnpt1 4.29 Tnc 2.37 Ypel5 0.50
Ptprq 4.23 Adcyap1r1 2.35
Slc47a1 4.16 Sec61a1 2.26
Atp6ap1l 4.12 Ak3 2.16
Kntc1 4.07 Arhgef17 2.04
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Secondly, we performed RNAseq on the total E16 cortex of controls and Uhrf1 cKO to detect 
transcriptional changes in all cell types including neurons. We observed 89 upregulated genes 
and 20 downregulated genes (Figure 4-8, Table 2), of which 30% were derepressed (Table 2, 
highlighted in red). Having detected more upregulated than down regulated genes with many 
being derepressed, these data suggest that Uhrf1 could play a more prominent role in 
transcriptional repression as opposed to activation. 
 
 
Fig.4-8 Transcriptional profiling in E16 full cortex in cKO and controls 
Expression plot of differentially regulated genes in the cKO compared to the control at E16. Red 
dots indicate upregulated genes, black dots indicate unregulated genes and blue dots indicate 
downregulated genes in the cKO. Fold change > 2 and p value < 0.05. X-axis and Y-axis values 
are FPKM (Fragments per million bases) from 100bp paired end RNAseq. 
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Table 2. Table of upregulated and down regulated genes in E16 full cortex 
Table depicting upregulated and downregulated genes from Fig.4-8B at E16. Red indicates 
derepressed genes. 
Results 
 
42 
 
To detect significantly altered pathways, our collaborator, Dr. Schotta (BMC, Munich), utilized the 
Gene Set Enrichment Analysis (GSEA) tool. GSEA is method used to determine if a defined set 
of genes is statistically different between 2 biological states. In the E16 germinal zone dataset, 
we observed an overrepresentation of genes involved in interferon alpha signaling (Figure 4-9A) 
and an underrepresentation of genes involved in oxidative phosphorylation (Figure 4-9B). 
Interestingly, in the E16 full cortex dataset, we did not observe any alteration in interferon 
signaling, suggesting that the proliferating cells are mainly altered in this pathway in Uhrf1 cKO. 
However, we did observe an underrepresentation of oxidative phosphorylation genes and DNA 
repair genes in the cKO (Figure 4-9C,D). Thus, loss of Uhrf1 in cortical NSCs, largely led to 
deregulation of cellular stress pathways. 
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Fig. 4-9 GSEA analysis at E16 detect deregulation of cellular stress pathways 
A-D. Graphs showing gene set enrichment analysis at E16 germinal zones (A,B) and full cortex 
(C,D), on gene expression datasets. Uhrf1 cKO showed underrepresentation of genes involved 
in oxidative phosphorylation for both datasets. However, only the germinal zones show 
upregulation of interferon signaling and only the full cortex shows an underrepresentation of DNA 
repair genes in the cKO, suggesting that the former occurs in NSCs and the latter in neurons. 
FDR < 25%. 
 
 
To understand, if these pathway alterations are maintained into later stages, we performed 
RNAseq in the entire cerebral cortex at postnatal day 5 (P5) in cKO and controls and observed 
96 upregulated and 40 downregulated genes (with 43 derepressed genes) (Figure 4-10A and 
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Table 3). We observed that interferon signaling was upregulated also at this later stage, in addition 
to the unfolded protein response (Figure 4-10B,C). Thus, there appeared to be an exacerbation 
of the cellular stress phenotype in postnatal stages. Additionally, we observed an 
underrepresentation of genes belonging to the LEIN_neuron markers dataset which are genes 
expressed the adult brain (Figure 4-10D). These data suggest that either maturation of neurons 
is impaired or the slight reduction of neurons at this stage could cause this dataset to be 
underrepresented. However, as we do not observe a clear reduction in cortical thickness at P5, 
we favor the former hypothesis as a more likely cause.  
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Fig. 4-10 GSEA analysis at E16 detect deregulation of cellular stress pathways 
A. Expression plot of differentially regulated genes in the cKO compared to the control at P5. Red 
dots indicate upregulated genes, black dots indicate unregulated genes and blue dots indicate 
downregulated genes in the cKO. Fold change > 2 and p value < 0.05. X-axis and Y-axis values 
are FPKM (Fragments per million bases) from 100bp paired end RNAseq. 
B-D. Graphs showing gene set enrichment analysis at P5 on hallmark and curated datasets. Uhrf1 
cKOs show underrepresentation of genes involved LEIN_neuron markers and an 
overrepresentation of genes involved in interferon signaling and unfolded protein response in the 
cKO. FDR < 25%. 
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Table 3. Table of upregulated and down regulated genes at P5 
Table depicting upregulated and downregulated genes from Fig.4-10A in P5 cerebral cortex.  
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4.3.2 Specific ERVs are activated in the developing cerebral cortex of Uhrf1 cKO 
Upregulation of interferon signaling has previously been described to be a consequence of 
retroviral activation (Chiappinelli et al. 2015). Therefore, we analysed the RNAseq datasets for 
deregulation of transposable elements. Indeed, we could observe a strong upregulation of a 
specific ERVs, namely IAPs, in all datasets, with IAPEz subtype exhibiting the strongest activation 
(Figure 4-11A-C, Table 4 and 5). Moreover, we did not detect other classes of transposable 
elements to be misregulated (Figure 4-11A-C). We interrogated the dataset further to identify 
deregulation of single transposable elements. Interestingly, we could observe upregulation of 
individual transposable elements in the P5 dataset (Figure 4-11D). 
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Fig. 4-11 IAP activation in Uhrf1 cKO in embryonic and postnatal stages 
A-C. Graph depicting activation of classes of repeat elements in E16 germinal zones (A), E16 full 
cortex (B) and P5 cerebral cortex (C). Red dots indicate repeat classes with significantly increased 
expression and blue dots indicate repeat classes with significantly downregulated expression in 
the cKO cerebral cortex compared to controls. X-axis and Y-axis values are FPKM (Fragments 
per million bases) from 100bp paired end RNAseq. 
D. Graph depicting individual repeat elements in E16 germinal zones (D), full cortex (E) and P5 
cerebral cortex (F). X-axis and Y-axis values are FPKM (Fragments per million bases) from 100bp 
paired end RNAseq. 
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Table 4. Table depicting repeat elements classes in E16 germinal zones 
Table showing upregulated and downregulated classes of transposable elements in E16 germinal 
zones of cKO compared to controls. 
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Table 5. Table depicting repeat elements classes in P5 full cortex 
Table showing upregulated and downregulated classes of transposable elements in P5 cortex of 
cKO compared to controls 
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The transcriptional upregulation of IAPs (about 100-fold) was confirmed by qRT-PCR at E16 and 
P5 with no activation of LINE-1 and SINE-B1 as an entire class (Figure 4-12A-C). To investigate 
the onset of IAP activation, we performed qRT-PCR from cerebral cortex tissue of control and 
cKO at E12 and E14. About 35 fold IAP activation at E12 was observed (Figure 4-12D) which 
steeped to about 70 fold at E14 (Figure 4-12E). 
 
 
         
Fig. 4-12 qRT-PCR showing IAP activation in the cKO 
A-E. RT-qPCR graph for IAP in control and cKO cerebral cortex in the E16 germinal zones (A), 
E16 full cortex (B), P5 cortex (C), E12 (D) and E14 (E) and for LINE-1 and SINE-B1. * indicates 
significance with p-value < 0.05 (n=4 for A,B,C,E; n=2 for D) Error bars indicate standard error of 
mean.  
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We investigated the correlation between deregulated genes and activated IAP transcripts. We 
could observe a low correlation, ranging 15-30% between activated IAP transcripts and 
deregulated genes (Table 6). These data suggest that activated IAP transcripts led to 
transcriptional activation of neighbouring genes and transposable elements in some instances. 
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Table 6. Deregulated genes in proximity to deregulated IAP transcripts  
Table depicting percentage and list of genes in proximity to IAPs, upregulated in Uhrf1 cKO. as – 
antisense; s – sense; i – intergenic; u – upstream from gene. 
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To determine if the upregulated IAP transcripts were being translated to protein, we performed 
immunostaining for IAP Gag protein at different embryonic and postnatal stages (Figure 4-13). 
We could not detect Gag staining at E12 (Figure 4-13A,B) while from E14 and upto P5 Gag 
staining was present in the cKO cerebral cortex (Figure 4-13C-H). 
 
 
Fig. 4-13 IAP Gag immunostaining in embryonic and postnatal stages 
A-H. Confocal images of coronal sections of cerebral cortex of controls (A,C,E,G) and cKO 
(B,D,F,H) at E12 (A,B) E14 (C,D), E16 (E,F) and P5 (G,H) cerebral cortex immunostained for IAP 
gag  and DAPI . 
Scale bar = 50µm; LGE – lateral Ganglionic Eminence; Ctx - cerebral cortex 
GM – grey matter; WM – white matter 
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4.4. Alterations in methylation and chromatin marks in Uhrf1 cKO 
 
4.4.1 Loss of DNA methylation in Uhrf1 cKO 
As Uhrf1 has been previously described to be involved in DNA methylation in ES cells, we sought 
to investigate this process in controls and Uhrf1 cKO. We assessed global DNA methylation by 
employing 2 restriction enzymes – MspI and HpaII which recognize CCGG sequences. When the 
internal cytosine is methylated in such sequences, HpaII cannot cleave the DNA, whereas MspI 
enzyme can cleave the internal CG. Thus, we performed restriction digests with both enzymes on 
genomic DNA extracted from E16 controls and Uhrf1 cKO cortices. Although MspI could digest 
both conditions comparably, HpaII could digest the cKO more than the control (Figure 4-14).  
 
 
 
Fig. 4-14 Uhrf1 cKO exhibit global hypomethylation at E16 
Restriction digests of E16 genomic DNA obtained from controls and Uhrf1 cKO cerebral cortex 
digested for HpaII and MspI. Note that both enzymes recognize CCGG sequence, however HpaII 
is unable to cut DNA when the internal cytosine is methylated. As more DNA was cut in the Uhrf1 
cKO samples this indicates less DNA methylation upon Uhrf1 deletion.  1kb is the 1kb DNA ladder 
and U is undigested DNA. 
 
To further ascertain if there is a loss of global methylation, we performed immunostaining for 5-
methyl cytosine (5mC) in embryonic stages. At E14 we could observe a severe loss of 5mC 
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immunoreactivity in the cKO cortex (Figure 4-15A,B). Interestingly, we detected some cells in the 
cKO cortex to persist in 5mC immunostaining. We performed co-stainings for Tbr2 (Figure 4-15C), 
Tbr1 (Figure 4-15D) and Pax6 (Figure 4-15E) with 5mC at E14 to identify the population of cells 
with persisting 5mC staining in the cKO. Some of the 5mC immunopositive cells did not colocalize 
with these markers, suggesting that these could be other cell types such as interneurons, glia or 
endothelial cells which did not arise from Emx1-Cre recombination. Thus, data from the restriction 
digests and immunostaining suggest a global loss of 5mC in Uhrf1 cKO. 
 
 
 
 
 
 
Fig. 4-15 Reduced 5mC immunostaining in the Uhrf1 cKO 
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A-I. Confocal images of coronal sections of cerebral cortex of controls (A) and cKO (B,C,D,E) at 
E14 immunostained for 5mC and DAPI and Tbr2 (C), Tbr1 (D) and Pax6 (E). Note that at 5mC 
staining is noticeably reduced in the cortex of cKO but not in the LGE wherein Uhrf1 was not 
deleted. Scale bar = 50µm.  
Abbreviations: LGE – lateral ganglionic eminence; Ctx – cortex; VZ – ventricular zone; CP – 
cortical plate 
 
4.4.2 Loss of 5mC in specific genes and transposable elements in Uhrf1 cKO  
To identify specific loci with reduced levels of 5mC, we employed Oxidative Reduced 
Representation Bisulfite Sequencing (Ox-RRBS) in collaboration with Dr. Reimenschneider 
(Regensburg University). In this technique, DNA is oxidized prior to treatment with bisulfite such 
that 5-hydroxy methyl cytosine (5hmC) is converted to 5-formyl cytosine (5fC). 5fC behaves in a 
similar manner to C during bisulfite treatment, as opposed to 5mC. This oxidation step thus allows 
an accurate measurement of 5mC levels in the relevant genomic DNA, differentiating between C, 
5mC and 5hmC. Therefore, we performed Ox-RRBS on genomic DNA isolated from E16 cortex 
of controls and Uhrf1 cKO. We observed a global loss of 5mC with all chromosomes exhibiting 
atleast 40% of loci with reduced 5mC levels (Figure 4-16A). Moreover, we detected alterations in 
850 differentially methylated promoters (DMRs) with atleast 25% loss of 5mC (FDR and q-value) 
(Table 7). We overlapped the DMRs at E16 with the deregulated genes from the E16 RNAseq 
dataset. An extremely low overlap of genes with loss of 5mC and deregulated transcripts was 
detected (Figure 4-16B). We further interrogated the dataset for transposable elements and could 
observe loss of 5mC in most classes, particularly IAP, LINE-1 and SINE-1 (Figure 4-16C). These 
data suggest that loss of DNA methylation is not deterministic for transcriptional activation for 
most genes, with the only exception being IAP ERVs. 
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Fig. 4-16 Ox-RRBS at E16 showing hypomethylated DMRs and REs in the cKO 
A. Graph depicting the percent of regions per chromosome with hypomethylation in the cKO 
cerebral cortex compared to the control. X-axis is the % of hypomethylated regions per 
chromosome and Y-axis is each chromosome. Note that every chromosome has a fairly equal 
level of hypomethylated regions. N=3 
B. Venn diagram overlapping the 850 DMRs from the E16 Ox-RRBS dataset with the E16 full 
cortex RNAseq upregulated genes (Fold change > 1.5). Note the minor overlap between the 2 
datasets.  
C. Graph showing percentage of hypomethylation in IAP, LINE-1 and SINE-B1 repeat classes in 
the E16 Ox-RRBS dataset. Note that all classes are equally hypomethylated. 
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Table 7. Table showing DMRs in the E16 Ox-RRBS dataset 
Table depicting the 100 most DMRs in the E16 cKO compared to control and their percentage of 
hypomethylation. 
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Moreover, we also investigated the correlation between individual LINE-1 elements and 
upregulated IAP transcripts. Interestingly, we observed the few upregulated LINE-1 transcripts to 
be in proximity to upregulated IAP transcripts (Figure 4-17). 
 
 
Fig. 4-17 Activated LINE-1 elements are in proximity to activated IAPs 
Graph depicting the correlation between hypomethylated LINE-1 elements and transcriptionally 
activated LINE-1 elements and IAPs at E16 in the cerebral cortex of controls and cKO. Fold 
change of LINE 1 elements from RNAseq is plotted against the Ox-RRBS data. The data shows 
few hypomethyated elements with high fold change in mRNA. Red dots indicate LINE-1 elements 
in proximity to IAP elements and black dots are all remaining LINE-1 elements. 
 
 
To confirm the specific loss of 5mC on retrotransposable elements, we employed bisulfite 
sequencing coupled with MiSeq. This method uses PCR amplification following oxidative bisulfite 
treatment of regions of interest. The PCR fragment is sequenced by next generation sequencing 
technology. In our case, we amplified a 500bp sequence of the IAP Gag region and a 200bp 
sequence of LINE-1 from controls and cKO cortex at E16. We could identify 27 CpGs in the IAP 
region with nearly 95% 5mC levels in the control which decreased to about 70% 5mC levels in 
the cKO (Figure 4-18A). In the case of LINE-1 we identified 9 CpGs in the control to also have 
about 80% 5mC levels which dropped to about 50% in the cKO (Figure 4-18B).  
Results 
 
61 
 
 
 
Fig 4-18 Ox-BS-Miseq analysis revealed hypomethylated CpGs in IAP and LINE-1 in the 
Uhrf1 cKO at E16 
A,B. Graphs depicting the percentage of methylation per CpG in the IAP (A) and LINE-1 (B) loci 
for cKO and control cerebral cortex. Y-axis indicates % of methylation and X-axis indicates 
individual CpGs. * indicates significance with a Fisher’s test with ** having p-value < 0.0001 and 
* with p-value < 0.001. N=1. 
 
 
4.4.3 Gain of 5hmC in Uhrf1 cKO on IAP elements 
Uhrf1 has been previously described to bind 5hmC (Frauer et al. 2011). Moreover, transcriptional 
activation has been associated with a gain of 5hmC (Wu et al.). Thus, to further shed light on the 
mechanisms governing IAP activation, we explored the 5hmC mark in the cKO. We first performed 
immunostaining against 5hmC at E12, E14 and E16 in controls and cKO cortices (Figure 4-19A-
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F). At E12, we did not observe any difference in 5hmC (Figure 4-19A,B). However, both at E14 
and E16, we detected cells in the germinal zones to ectopically express 5hmC (Figure 4-19D,F). 
This was in contrast to the control wherein 5hmC was only observed in the cortical plate where 
neurons reside (Figure 4-12C,E). This distribution in the control was in concordance with previous 
observations (Hahn et al.2013). 
 
 
Fig.4-19 Ectopic 5hmC immunolabelled cells in the cKO at embryonic stages 
A-F. Confocal images of coronal sections of controls (A,C,E) and cKO (B,D,F) immunostained for 
5hmC at E12 (A,B), E14, (C,D) and E16 (E,F). Note the presence of ectopic 5hmC cells in the 
cKO at E14 and E16. Scale bar = 50µm.  
Abbreviations: CP- cortical plate; VZ – ventricular zone; SVZ – subventricular zone 
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We investigated this increase in 5hmC by exploring the genomic loci which had accumulated 
5hmC levels in the cKO compared to control. To address this question, we performed hydroxy 
methylated DNA immunoprecipation followed by next generation sequencing (hmeDIPseq) on 
E16 controls and cKO. In order to enrich for the cells ectopically expressing 5hmC in the cKO, we 
subdissected  the cortex to remove the cortical plate and enrich for the germinal zones as was 
previously described for the E16 RNAseq experiment. hmeDIPseq was performed on the tissue 
enriched for the germinal zones. Interestingly, we did not observe any significant changes of 
5hmC in coding regions between control and cKO. However, when we investigated 1200 
repetitive element classes for 5hmC levels, we observed 4 subtypes of IAP elements to have 
atleast 2-fold enrichment of cKO over control (normalized to input) (Figure 4-20A and Table 8). 
Cumulative coverage plots were generated for all IAP elements in cKO and control, showing an 
increase in 5hmC peaks at the SHIN region of the Gag portion of IAP sequence (Figure 4-20B). 
The SHIN region or Short Heterochromatin Inducing Region is a sequence which has been 
previously described to induce the formation of heterochromatin in ES cells (Sadic et al. 2015). 
Some additional peaks were also observed on the LTR region which acts as promoters for IAP 
(Figure 4-20B). These data were confirmed with hmeDIP-RT-qPCR for IAP and negative regions 
(Figure 4-20C).  
Moreover, we utilized the data from the Ox-BS-Miseq experiment to deduce relative levels of 
5hmC in the control and cKO at E16 on IAP and LINE-1. We observed an increase of about 1.4% 
5hmC in IAP in the cKO compared to the control (Figure 4-20C). Interestingly, we observed an 
increase of only 0.4% 5hmC for LINE-1 in the cKO compared to the control (Figure 4-20C). These 
data also indicate the actual levels of 5hmC might be relatively low in the cKO, although higher 
than the control. 
Thus, in summary, the above data indicate a significant accumulation of 5hmC specifically on IAP 
in Uhrf1 cKO.  
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Fig.4-20 Ectopic accumulation of 5hmC is specifically on IAPs in the cKO 
A.Graph depicting 1200 repeat elements classes from the E16 germinal zones hmeDIPseq 
dataset of control and cKO cerebral cortex. X-axis and Y-axis are log fold enrichment of control 
and cKO over input from 50bp single end sequencing. Red dots indicate repeat classes with > 2 
fold higher 5hmC in cKO over control. P-value < 0.05. RPKM is reads per million bases. 
B. Cumulative coverage plots of RPKM reads for IAP in control and cKO from the hmeDIPseq 
dataset. Note that the cKO has an accumulation of peaks in the Gag and LTR regions compared 
to the control. 
C.Graph depicting the relative increase in 5hmC in controls and cKO on the IAP and LINE-1 loci 
from the Ox-BS-MiSeq experiment from Figure 4-18. 
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Table 8. Table depicting the repeat elements classes with upregulated 5hmC from the 
hmeDIPseq dataset 
 
4.4.4 Assessing changes in histone marks in the cKO 
Data from the RNAseq and DNA methylation analysis revealed differences in the behavior of 
repeat classes. More specifically, although both IAP and LINE-1 elements lost 5mC in the Uhrf1 
cKO, only IAP showed activation on the transcript level. Thus, we hypothesized that the two loci 
could differ in chromatin marks such as histone methylation. It has been described that the 
H3K9me3 can act as a repressive modification (Volpe et al. 2002). Thus, we speculated that 
levels of H3K9me3 could differ between IAP and LINE-1 in the control and cKO cortices, thus 
translating into transcriptional activation for one and not the other. Therefore, in collaboration with 
Dr. Cernilogar at the Biomedical Center, Munich, we performed ChIP experiments for H3K9me3 
in control and cKO cortices at E16. Contrary to our hypothesis, we did not observe a significant 
change in H3K9me3 between cKO and control for IAP and LINE-1 (Figure 4-21).  
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Fig. 4-21 Comparable repressive histone marks in the cKO and control at E16 
Graph depicting percentage of input in control and cKO at E16 following ChIP for H3K9me3 on 
IAP, LINE-1 and Polrmt (positive controls) and Gapdh (negative controls). Note that there is no 
significant difference between controls and cKO on the loci. Error bars indicate standard error of 
mean. n=3 
 
4.5. Manipulation of Tet enzymes to rescue IAP activation 
 
4.5.1 In vivo knockdown of Tet enzymes by in utero electroporation of the cKO cortex 
Tet enzymes have been described to be responsible for converting 5mC to 5hmC. Since we 
observed a specific increase in 5hmC on IAPs only, we hypothesized that the increase in 5hmC 
could be causative for the observed IAP transcriptional activation. Thus, we sought to knockdown 
Tet enzymes in the cKO cortex to test whether this would reduce IAP transcripts. We focused on 
Tet2 and Tet3 as it had been previously described to be the most highly expressed Tet genes in 
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the embryonic cerebral cortex (Hahn et al. 2013). We obtained previously published shRNA 
constructs and a scrambled control construct (Hahn et al. 2013). Using in utero electroporation, 
we electroporated a combination of Tet2/Tet3 shRNA into cKO embryos at E13. Firstly, we 
observed no significant difference in the distribution of GFP positive cells in cKO embryos 
electroporated for Scrambled or Tet2/Tet3 shRNA (Figure 4-22A,B). Moreover, we did not 
observe any difference in GFP distribution of cKO and control embryos electroporated for Tet2/3 
shRNA (Figure 4-22B,C). These data suggest that the Tet knockdown does not result in any 
obvious changes in cell fate. It is also interesting to note, that the distribution of GFP+ve cells in 
the cKO embryos indicates that neurons are migrating adequately to their final destination, the 
cortical plate (Figure 4-22A,B). We isolated GFP+ve and GFP-ve cells by FACS from embryos 
electroporated for Tet2/3 in cKOs at E16 (Figure 4-22D) and performed qRT-PCR for the IAP 
region (Figure 4-22E). Paired t-test analysis was carried out on these samples as the 2 population 
of GFP+ve and GFP-ve cells were derived from the same embryo in each experiment. The 
analysis showed a significant reduction of IAP mRNA levels in the cells electroporated for Tet 
constructs as compared to the surrounding non-electroporated cells (Figure 4-22E). Importantly, 
IAP was already activated in the cKO at the time of electroporation. Thus, the small degree of IAP 
reduction after Tet knockdown is hence expected as only the further increase of IAP can be 
blocked. 
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Fig. 4-22 Tet knockdown in the cKO partially rescued IAP transcriptional activation 
A-C. Confocal images of coronal sections of cerebral cortex of E16 cKO (A,B) and control (C) 
embryos electroporated for Tet2/3 shRNA with GFP (B,C) and Scrambled shRNA with GFP (A) 
at E13 and immunostained for GFP and DAPI. Scale bar =50µm.  
D. FACS plots showing gating for GFP+ve (green dots) and GFP -ve (red dots) cells in E16 cKO 
embryos electroporated at E13 for Tet2/3 shRNA. 
E. Graph depicting qRT-PCR for Uhrf1 in E13 cKO embryos electroporated for Tet2/3 shRNA 
showing significantly less IAP mRNA in GFP+ve cells compared to GFP-ve cells. * indicates 
significance with a paired t-test with p-value < 0.05.  Error bars indicate standard error of mean. 
N=3. 
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We performed additional experiments to understand if a downregulation of the IAP gag protein 
could be observed following Tet knockdown. We electroporated cKO embryos at E13 and 
analysed sections of the cerebral cortex at E16. In addition to electroporating Tet2/Tet3 shRNA, 
was also electroporated Scrambled shRNA in other cKO and control embryos. We performed an 
immunostaining for IAP Gag in the cKO embryos and quantified the proportion of Gag in the 
GFP+ve cells for the Scrambled and Tet shRNA conditions (Figure 4-23A,B). We separated the 
quantifications between cortical plate and the rest of the cortex (VZ, SVZ and IZ). This is because 
we hypothesized that the knockdown would be more pronounced in the germinal zones compared 
to the differentiated cortical plate. Although we could observe a trend towards a slight decrease 
in the IAP Gag immunostaining in cKO embryos electroporated for Tet2/3 shRNA, the difference 
was not statistically significant (Figure 4-23C). Thus, further time might be needed for reduction 
in Gag protein to become detectable. 
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Fig. 4-23 Assessing changes in IAP Gag immunostaining following Tet knockdown in the 
cKO 
A,B. Confocal images of coronal sections of E16 cerebral  cortex cKO embryos electroporated 
for Scrambled shRNA (A) and Tet2/3 shRNA (B) at E13 and immunostained for GFP and DAPI 
and IAP Gag. Scale bar =50µm. White arrows indicate cells positive for IAP Gag and yellow 
arrows indicate cells negative for IAP Gag. 
C. Graph depicting quantification of the percentage of IAP Gag +ve cells over GFP+ve cells from 
A,B sections. Error bars indicate standard error of mean. n=3 
VZ – ventricular zone; SVZ – subventricular zone; IZ – intermediate zone; CP – cortical plate 
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4.5.2 Generating an in vitro system to investigate the relationship between Tet enzymes 
and IAP activation 
The IAP transcript activation was evident already from E12 and could have started prior to this 
stage. Thus, it was technically not possible to downregulate the Tet enzymes prior to IAP 
activation, by in vivo electroporation. Thus, we sought out to generate an in vitro system wherein 
the Tet hypothesis regarding IAP activation could be better tested, wherein Tet enzymes could 
be manipulated simultaneously as Uhrf1. We generated an in vitro system of self-renewing 
multipotent neural stem cells from Uhrf1 floxed E13 cortices, as previously established (Conti et 
al. 2005; Onorati et al 2010). To stably knockout Uhrf1 in these Uhrf1 NS cells, we added Cre 
protein to the media and analysed the cells after 4 days by immunostaining for Uhrf1. We could 
observe that in the condition without Cre, all cells were positive for Uhrf1 (Figure 4-24A). However, 
in the condition with Cre, some cells lost or downregulated Uhrf1 protein levels (Figure 4-24B). 
Also, qRT-PCR indicated a 20-fold reduction of Uhrf1 mRNA (Figure 4-24C). We first 
characterized the system by assessing cell death with the Annexin-V assay. NS cells treated with 
and without Cre were harvested after 4 days in vitro and analysed using the FACS with the 
Annexin V kit. We observed a trend towards an increase in cells expressing Annexin-V in the 
condition with Cre (Figure 4-24D). However, the increase was not statistically significant, possibly 
due to the high variation between experiments. These data indicate that at least part of the cellular 
phenotypes observed in vivo could be recapitulated in vitro. 
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Fig. 4-24 Establishing an in vitro system of Uhrf1 KO NS cells 
A-B. Epifluoroscence images of Uhrf1 floxed NS cells without Cre induction (A) and with with Cre 
induction (B). After 4 days in vitro, the cells were immunostained for Uhrf1 and DAPI. Scale bar = 
50µm. 
C. qRT-PCR for Uhrf1 in Uhrf1 floxed cells after 4 days in vitro with and without Cre induction. 
Error bars indicate standard error of mean. * indicates significance with unpaired t-test with p-
value = 0.02. N=4 for –Cre and n=8 for + Cre. 
D. FACS plots for Uhrf1 floxed NS cells analysed for cell death with the Annexin-V assay kit. Cells 
were treated with and without Cre and analysed after 4 days in vitro. Annexin gates were set using 
unstained cells.  
E. Graph indicating increase in annexin +ve cells in the Cre condition. Note that the standard error 
shows high variation between replicates and thus the data is not significant. N=4. 
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To characterize if the molecular aspect of the phenotype was replicated in vitro, we first probed 
the cells for expression of IAP, LINE-1 and SINE-B1 elements. Indeed, we could observe about 
25-fold induction of IAP in cells treated with Cre with only a mild upregulation of LINE and SINE 
compared to untreated controls (Figure 4-25A). In order to assess changes in methylation, we 
performed stainings for 5mC and observed a loss of 5mC in cells treated with Cre as expected 
from the in vivo data (Figure 4-25B,C). We further confirmed the changes in 5mC using the 
Oxidative Bisulfite Sequencing method coupled with MiSeq, as was performed for the in vivo 
tissue. Indeed, we could observe a significant loss of 5mC (about 15% loss) on some of the CpGs 
in both the IAP and LINE-1 loci (Figure 4-25D,E). We could also infer the levels of 5hmC from this 
experiment and detected a gain of 4.3% for IAP with only 0.2% for LINE-1 in the condition upon 
Cre application compared to cells without Cre (Figure 4-25F). Thus, in summary, we could also 
recapitulate some of the molecular phenotypes of the in vivo phenotype in this in vitro system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
74 
 
 
Results 
 
75 
 
Fig. 4-25 Molecular characterization of the Uhrf1 floxed in vitro system 
A.qRT-PCR for IAP, LINE-1 and SINE-B1 in Uhrf1 floxed NSCs treated with and without Cre and 
analysed after 4 days in vitro. Note the increase of IAP mRNA in the Cre condition. Error bars 
indicate standard error of mean. * indicates significance with unpaired t-test with p-value. N=3. 
B,C. Epifluoroscence images of Uhrf1 floxed NSCs treated with (C) and without Cre (B) 
immunostained for 5mC. Observe loss of 5mC staining in the Cre condition. Scale bar = 50µm. 
D,E. Graphs depicting the percentage of methylation per CpG in the IAP (D) and LINE-1 (E) loci 
in Uhrf1 floxed NSC treated with and without Cre and analysed by Ox-BS-MiSeq after 4 days in 
vitro. Y-axis indicates % of methylation and X-axis indicates individual CpGs. * indicates 
significance with a Fisher’s test with ** having p-value < 0.0001 and * with p-value < 0.001. N=1 
F. Graph depicting the relative increase in 5hmC in Uhrf1 floxed NSCs treated with and without 
Cre on the IAP and LINE-1 loci from the Ox-BS-MiSeq experiment from D,E. 
 
 
Having successfully established an in vitro system for Uhrf1 cKO, we performed knockdown 
experiments for the Tet enzymes. We transfected shRNA constructs for Tet2/Tet3 and Scrambled 
in Uhrf1 NS cells and simultaneously treated the cells with and without Cre recombinant protein. 
After 4 days in vitro, we harvested all the cells in both conditions and assessed IAP expression. 
We observed a significant difference in IAP mRNA in the Tet shRNA plus Cre condition as 
compared to the Scrambled shRNA plus Cre (Figure 4-26). We performed paired t-test analysis 
since the same pool of cells were electroporated and treated with Cre.  
Thus, in summary, we observed that downregulation of Tet enzymes in Uhrf1 floxed NS cells 
treated with Cre could partially suppress the IAP mRNA upregulation. 
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Fig. 4-26 Tet knockdown in Uhrf1 floxed NSCs could partially rescue IAP activation 
qRT-PCR for IAP in Uhrf1 floxed NSCs treated with and without Cre and electroporated for 
Scrambled or Tet2/Tet3 shRNA. Note the significantly less IAP mRNA levels in Uhrf1 floxed NSCs 
treated with Cre and electroporated for Tet2/Tet3 shRNA compared to the Scrambled shRNA 
condition. Error bars indicate standard error of mean. * indicates significance with a paired t-test 
with p-value = 0.02 and 0.04 respectively. N=3. 
 
4.6 Investigating changes in the proteasome of cKO cortices and controls 
As described in the introduction, Uhrf1 protein has several domains, one of which is the RING 
domain. This domain can act as an E3 ubiquitin ligase, thereby controlling the stability of certain 
(proteins. This was observed in the case of the protein Pml (Guan et al. 2013). Thus, we 
investigated the proteasome of the cKO and control cortices by performing mass spectrometry at 
E16 of the protein lysates. As Uhrf1 is present in the nucleus, we used a cellular fractionation 
protocol to separate the nucleus and cytoplasm. Indeed, the nuclear fraction was highly enriched 
for nuclear proteins, as observed by a western blot for histone H3 and the other fraction was 
highly enriched for cytoplasmic proteins, as observed by a western blot for beta III tubulin (Figure  
4-27A). First, we performed a test experiment of a wild-type E15 cerebral cortex lysate to ascertain 
the extent and nature of proteins which could be detected via mass spectrometry in this cell type. 
We could detect about 1400 proteins from this experiment with about 300 protein specific for each 
fraction (4-27B). Following this, we performed mass spectrometry on lysates from the cKO and 
control cortices at E16. We could observe several proteins to be significantly upregulated in the 
cKO as compared to the control in both the nucleus (Figure 4-27C) and the cytoplasm (Figure 4-
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28D; Table 9). The most upregulated protein was Nox3, a NADPH oxidase with a nearly 100-fold 
upregulation in the mutant. This would be consistent with the loss of a E3 ubiquitin ligase 
mediating degradation, hence increasing Nox3 levels. Interestingly, we had evidence for oxidative 
stress also from the RNAseq data in the cKO and now found a protein increasing reactive oxygen 
species which could be a potential cause for the oxidative stress. 
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Fig. 4-27 Proteosome analysis of Uhrf1 cKO mutants at E16 
A.Western blots for Histone 3 and Beta III tubulin in E15 cortical lysates fractionated for the 
nucleus and cytoplasm. Note the presence of Histone H3 only in the nuclear fraction and beta III 
tubulin only in the cytoplasmic fraction. 
B,C. Volcano plots of the proteasome analysis of cerebral cortex of E16 cKO and controls by 
mass spectrometry depicting proteins between the controls and cKO in the nuclear (B) and 
cytoplasmic (C) fractions. 
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Table 9. Table depicting deregulated proteins in E16 Uhrf1 cKO and control lysates 
detected by label-free mass spectrometry 
Table enlisting upregulated and downregulated proteins in the Uhrf1 cKO compared to controls 
at E16. 
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4.7. Generating neural stem cells from Uhrf1 KO ES cells 
Previous studies have shown that loss of Uhrf1 in ES cells resulted in activation of IAPs (ref). 
Moreover, in our study we could also determine IAP activation in a Uhrf1 KO of neural stem cells 
both in vivo and in vitro. Thus, we sought to determine if neural stem cells derived from Uhrf1 KO 
ES cells still maintained IAP activation and exhibited any cellular phenotype. In collaboration with 
Dr. Fabio Spada at the LMU, we received NS cells which had been derived from Uhrf1 KO ES 
cells and corresponding controls. Firstly, we immunostained these cells for IAP Gag and could 
observe a strong activation of IAP in the KO cells compared to WT controls (Figure 4-28A,B). 
Interestingly, we also observed a strong upregulation of H2AX staining in the KO cells compared 
to controls (Figure 4-28C,D). As H2AX has been described to label DNA double stranded breaks, 
this result could indicate genomic instability in the Uhrf1 KO NS cells.  
Thus, these data further indicate that once IAPs are ectopically activated certain cell types, in this 
case ES cells, they are maintained in all subsequent generations (such as NS cells in this case 
and neurons in the cKO cerebral cortex). 
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Fig. 4-28 IAP is activated in NSCs derived from Uhrf1 ES KO cells 
A-D. Epifluoroscence images of wild-type and Uhrf1 KO NSCs immunostained for IAP Gag (A,B) 
and H2AX (C,D) indicating IAP activation and genomic instability.  
 
 
4.8. Conditional knockout of Uhrf1 in adult neurogenic niches 
 
4.8.1 Loss of Uhrf1 in the adult subependymal zone and dentate gyrus – further 
characterization of the cellular phenotype 
Previous data from our lab (Bayam 2014) has shown that loss of Uhrf1 in the adult neurogenic 
niches (subependymal zone and dentate gyrus) have resulted in reduced proliferation of transit-
amplifying progenitors (TAPs) and neuroblasts. The adult cKO was generated by using 
GlastCreERT2; Uhrf1 flox; CAG mice wherein Cre was activated with Tamoxifen induction (Mori et 
al. 2006). The reduction in proliferation was previously assessed by immunostaining for Ki67 and 
1 hour BrdU pulses.  
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To understand if the reduction in neuroblasts in the SEZ and DG was due only because of reduced 
proliferation or due to increased cell death, we first performed TUNEL analysis at 9dpi post 
induction in the DG (Figure 4-29A). We did not observe a significant difference in % of TUNEL+ve 
cells over GFP+ve at 9dpi in the DG (Figure 4-29B). We also analysed 4 weeks pi in the SEZ. 
Although we observed a mild increase in TUNEL+ cells in the adult cKO SEZ, in total there were 
very few in the SEZ of both the cKO and control (Figure 4-29C). Thus, we concluded that although 
cell death could contribute towards the reduction in TAPs and neuroblasts, it is not the main 
cause. 
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Fig-4-29 Cell death analysis in the adult cKO of the SEZ and DG 
A. Confocal images of sagittal sections of the adult DG of cKO stained with the TUNEL kit to label 
apoptotic cells, GFP to label recombined cells and DAPI at 9 days post tamoxifen induction.  
B. Graph depicting quantifications for numbers of TUNEL+ve cells per GFP+ve cells in adult 
control and cKO at 9dpi in DG, showing no difference in TUNEL+ve cells in the adult control  and 
cKO. Error bars indicate standard error of mean. n=2. 
C. Graph depicting quantifications for numbers of TUNEL+ve cells among GFP+ve cells per area 
in adult control and cKO from at 4 weeks post induction in the SEZ showing a slight increase in 
the adult cKO. n=1 for cKO and 2 for Ctrl. 
 
 
 
 
Although a reduction in GFP+ve cells was previously also observed in the SEZ (Bayam 2014), 
the numbers of GFP+ve cells in the olfactory bulb appeared unchanged at 4 weeks post induction. 
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Thus, we investigated if the recombined cells in the adult cKO and controls were changed in the 
olfactory bulb at 4 months post induction. We quantified numbers of GFP+ve cells in different 
layers of the olfactory bulb in the cKO compared to the control but observed no significant change 
in numbers (Figure 4-30A-C). 
Therefore, we concluded that although loss of Uhrf1 in the adult SEZ resulted in impaired 
proliferation and a reduction in cell types in the SEZ, there was a compensation for this loss in 
the olfactory bulb, resulting in comparable number of neurons generated from the recombined 
GFP+ve cells that migrated to and survived in the OB. 
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Fig-4-30 Comparable recombined cells in the olfactory bulb of the adult control and cKO 
of the SEZ 
A,B. Confocal images of sagittal sections of the adult olfactory bulb of control (A) and cKO (B) 
stained with GFP to label recombined cells and DAPI at 4 months post tamoxifen induction. Scale 
bar = 50µm 
C. Graph depicting quantifications for numbers of GFP+ve cells per area in adult control and cKO 
from A,B, showing no difference in the control and adult cKO. Error bars indicate standard error 
of mean. n=2. 
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4.8.2 Differences in IAP activation in the adult cKO of the SEZ and dentate gyrus 
To investigate the molecular mechanisms underlying the phenotypes in the adult cKO, we first 
examined if there were any changes in DNA methylation. We performed immunostaining for 5mC 
and 5hmC in the SEZ at 9 days post induction. We could not observe any significant changes in 
5mC in GFP+ve cells in the cKO and control SEZ (Figure 4-31A,B).  
 
Fig. 4-31 Assessing changes in methylation marks by immunostaining in adult cKO of SEZ 
and dentate gyrus 
A-B. Confocal images of sagittal sections of the SEZ control (A) and adult cKO (B) immunostained 
for 5mC and 5hmC at 9 days post induction in the SEZ. Immunostaining for 5mC and 5hmC 
appear largely unchanged between controls and cKO. White arrows indicate GFP+ve cells 
positive for 5mC and 5hmC. Scale bar = 50µm. 
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In order to ascertain if IAP is activated in the adult cKO, we performed immunostaining for IAP 
Gag protein at 9 days and 4 weeks post induction (Figure 4-32) in both SEZ and dentate gyrus. 
At 9 days post induction, we mainly observed IAP to be activated in the SEZ (Figure 4-32A,B). 
The NSCs from the SEZ migrate through the RMS and to the OB so at 4 weeks post induction we 
performed IAP Gag staining. We detected IAP additionally in the rostral migratory stream and 
olfactory bulb of the adult cKO (Figure 4-32C,D). 
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Fig. 4-32 IAP activation in the adult SEZ cKO 
A-D. Confocal images of sagittal sections of control (A) and adult cKO (B,C,D) immunostained for 
IAP Gag at 9 days post induction (A,B) and 4 weeks post induction (C,D) in the SEZ. Note that 
IAP Gag immunostaining is detectable only in the cKO. Scale bar = 50µm 
 
Surprisingly, we did not observe IAP activation in the adult cKO of the dentate gyrus, even at 4 
weeks post induction (Figure 4-33A,B). Thus, these data indicate specificity for Uhrf1 in IAP 
regulation in different neurogenic niches. 
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Fig. 4-33 IAP is not activated in the adult dentate gyrus cKO 
A-D. Confocal images of sagittal sections of control (A) and adult cKO (B) immunostained for IAP 
Gag at 4 weeks post induction in the dentate gyrus. Note that IAP Gag immunostaining is not 
detectable in the control and cKO. Scale bar = 50µm 
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5. Discussion 
5.1. Expression of Uhrf1 in the developing cerebral cortex 
Comprehensive analysis of Uhrf1 expression in the embryonic cortex provided several insights. 
From mRNA and immunohistochemistry, we could observe that Uhrf1 is largely present as protein 
and mRNA in early stem cells of the neurogenic lineage and is strongly downregulated in later 
differentiated cells. Uhrf1 was found to be expressed highly by embryonic radial glia and Uhrf1 
immunostaining was prominent in the ventricular zone wherein radial glial cells reside. 
Interestingly, Uhrf1 protein was mostly downregulated in the intermediate progenitors labelled by 
Tbr2, with only few Tbr2+ve cells having low levels of Uhrf1 (Ramesh et al. 2016). Intermediate 
progenitors could not be isolated via FACS with current protocols and thus it is still unclear the 
extent of Uhrf1 mRNA present in these cells. Finally, we examined newborn neurons in the 
embryonic cortex for Uhrf1 expression and immunostaining. Uhrf1 expression in newborn neurons 
was extremely low (about 40-fold lower than radial glia). Moreover, Uhrf1 immunostaining was 
largely absent in the differentiated zones at E12. We could also observe Uhrf1 immunostaining in 
the ventricular zone of the LGE, suggesting a role for Uhrf1 in GE radial glia proliferation and 
differentiation. In the adult neurogenic niches, we detected Uhrf1 mRNA in the SEZ, indicating 
that it is expressed in aNSCs and progenitors. These data support published findings from our 
lab, wherein Uhrf1 is largely detected in TAPs and to a lower extent in aNSCs (Ramesh et al. 
2016). Thus, the expression of Uhrf1 differs between embryonic and adult neurogenesis, wherein 
embryonic NSCs have high levels of Uhrf1 and the embryonic TAPs have low levels and the 
contrast is observed for the adult SEZ. 
The expression of Uhrf1 in the neurogenic lineage is similar to that observed in other lineages 
wherein Uhrf1 is largely present in proliferating cells such as in skin stem cells (Sen et al. 2010), 
in regulatory T-cells (Obata et al. 2014), T-cell progenitors (Cui et al. 2016) and in hematopoietic 
stem cells  (Zhao et al. 2016). Additionally, Uhrf1 was shown to be downregulated during skin 
stem cell differentiation (Sen et al. 2010) and this was also observed by us in the developing 
cortex, with its low levels in intermediate progenitors and near absence in neurons.  
 
5.2. Cellular function of Uhrf1 in the embryonic cerebral cortex 
Uhrf1 null mice are embryonically lethal, probably due to mid-gestational lethality (Muto et al. 
2002). Thus, in order to study Uhrf1 function, only conditional knockout mice can be utilized. Since 
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we were interested in studying Uhrf1 function specifically in cortical neurogenesis we employed 
a Cre specific to the dorsal telencephalon, namely, Emx1-Cre (Iwasato et al. 2000; Cappello et 
al. 2006).  Moreover, since we observed Uhrf1 immunostaining in radial glia of both the developing 
cerebral cortex and the ganglionic eminence, we could monitor loss of Uhrf1 using the GE as an 
internal control. We observed loss of Uhrf1 only in the dorsal telencephalon at E12, with no loss 
in the GE. Previous data have shown that loss of Uhrf1 in the embryonic cortex leads to loss of 
cortical neurons at 1 month of age with no apparent changes in embryonic radial glia and 
progenitors (Bayam. 2014). We probed for defects in proliferation with Ki67 staining at E16 and 
observed no changes in numbers. However, we did detect an increase in non-apical Ki67+ve cells 
in the cKO compared to the control. As we did not observe defects in proliferation of cortical 
progenitors, we hypothesized that the reduction in cortical neurons could arise from premature 
neuronal differentiation. We performed Tuj1 and Tbr1 staining at E16 to address this question. 
We could not detect any ectopic neurons in the germinal zones or any difference in the numbers 
of Tbr1+ve cells between the cKO and controls. These phenotypes are in contrast to that which 
was studied in T-regulatory cells and hematopoietic stem cells wherein loss of Uhrf1 lead to 
defects in stem cell or progenitor proliferation (Obata et al. 2014; Zhao et al. 2016). Thus, although 
Uhrf1 is known to be expressed primarily in proliferating cells, it does not always play an active 
role in proliferation and differentiation in the cell type of its expression. These findings are in 
contrast to those which were observed for Uhrf1 in other systems. In the T-regulatory cells, loss 
of Uhrf1 resulted in defects in proliferation due to the upregulation of p27kip1, a cell cycle inhibitor 
(Obata et al. 2014). In the zebrafish lens, loss of Uhrf1 and Dnmt1 led to defect in lens 
development and maintenance (Tittle et al. 2011). Moreover, loss of Uhrf1 in HSCs and skin stem 
cells impaired their self-renewal (Sen et al. 2010; Zhao et al. 2016). Thus, ours is the first study 
wherein conditional loss of Uhrf1 in multipotent stem cells (cortical radial glia) did not result in a 
significant aberration of self-renewal, proliferation of initial differentiation.  
To further understand the underlying cause for the reduction in cortical neurons in 1 month old 
mice, we probed the cKO for cell death. We hypothesized that the reduction in neurons could 
arise from increase cell death. In fact, previous data have indicated some cell death at mid-
neurogenic stages in the Uhrf1 cortical cKO compared to controls (Bayam. 2014). We investigated 
the onset of cell death by examining the cKO for TUNEL+ve cells at E12. Indeed, we observed 
about a 4-fold increase in TUNEL+ve cells at E12 in the cerebral cortex of the cKO compared to 
controls. This extent of increase in TUNEL+ve cells in the cKO at E12 was similar to that which 
was observed at E14 and E16 (Bayam 2013). Thus, although some cell death occurs at embryonic 
stages, this is not translated into a detectable reduction in either progenitors or neurons. These 
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data suggest that the cerebral cortex of the cKO is able to compensate the cell death without 
resulting in significant changes in progenitors or neurons.  
Loss of Uhrf1 has been shown to cause apoptotic death in certain cell types such as cancer cells 
and human cell lines (Dai et al. 2013; Ge et al. 2016; Matsushita et al. 2016). One of the described 
mechanisms involves the interaction of Uhrf1 with Tip60 wherein loss of this binding facilitates 
binding of Tip60 to p53 to acetylate it and activate its downstream targets for apoptosis (Dai et al. 
2013). However, it has also been shown that loss of Uhrf1 in cancer cells can lead to an increase 
in caspase-8 dependent apoptotic cell death, which occurs in a p53-independent manner (Tien et 
al. 2011). Thus, it is possible that the cell death we are observing might occurring in a p53 
dependent or independent manner. Additionally, we detected an increase in Nox3, a NADPH 
oxidase which increases reactive oxygen species in cells. Thus, it is likely that Nox3 upregulation 
can lead to ferroptosis, a form of cell death related to increased ROS (Yu et al. 2016). 
As we did not observe defects in radial glia/progenitor proliferation or initial neuronal 
differentiation, we investigated early postnatal stages wherein terminal neuronal differentiation 
occurs. Indeed, we could only observe a decrease in the thickness of the cortex from P7. At E16 
and even P2, we could not detect a significant change in cortical thickness. Thus, we 
hypothesized that cell death was possibly aggravated during early postnatal cortical development. 
We investigated TUNEL staining at P2 and P7 of the cKO compared to controls. At P2 we 
detected almost an 11-fold increase in TUNEL+ve cells of the cKO and at P7 it reduced to about 
6-fold higher in the cKO.  These data suggest that loss of Uhrf1 resulted in a late 
neurodegenerative phenotype wherein postnatal cell death was the possible primary cause for 
the severe reduction of cortical neurons.  
In fact, conditional deletion of Dnmt1 in the developing cerebral cortex using also Emx1-Cre 
resulted in a highly comparable phenotype to that of Uhrf1 (Hutnick et al. 2009). Dnmt1 cKO 
exhibited a severe reduction of cortical thickness with massive cell death occurring at embryonic 
stages (Hutnick et al. 2009). On the contrary, conditional deletion of genes regulating histone 
marks displayed a range of phenotypes. ESET (involved in setting the H3K9me3 mark) cKO in in 
the cerebral cortex (using Emx1-Cre) led to defects in proliferation and initial neurogenic 
differentiation (Tan et al. 2012), suggesting differing role for genes involved in H3K9 methylation 
and DNA methylation. In fact, as observed by our H3K9me3 ChIP experiments, loss of Uhrf1 did 
not significantly change this histone mark. Interestingly, conditional deletion of G9a, a histone 
methyltransferase which is involved in setting H3K9me2, led to a similar phenotype as was 
observed here with Uhrf1 (Kumar 2014). This could be due to fact that Uhrf1 has been shown to 
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bind G9a (Kim et al. 2009), suggesting an interplay between these molecules also in the 
embryonic cortex.  
We also investigated changes in gliogenesis in the cKO cortices. We did not observe any 
activation of Gfap in the Uhrf1 cKO, which is in contrast to that observed in Dnmt1 cKO, wherein 
precocious astroglial differentiation was detected (Fan et al. 2005). This premature Gfap 
activation in Dnmt1 cKO NSCs was attributed to deregulated Jak-Stat signaling pathway (Fan et 
al. 2005). This pathway was not deregulated in our Uhrf1 cKO study, suggesting some differing 
transcriptional targets for Uhrf1 and Dnmt1. However, we did observe some genes expressed in 
the germline and some x-linked genes to be commonly regulated in both the Dnmt1 and Uhrf1 
cKO RNAseq datasets at P5. The only time point wherein we observed Gfap activation in the 
cerebral cortex was in 1-month old cKO mice. Gfap activation, as part of reactive  gliosis, has 
been linked to neurodegeneration (Maragakis and Rothstein 2006). Thus, the observed Gfap 
activation is probably due to neuronal death observed in the Uhrf1 cKO. We also analysed 
microglia activation in our Uhrf1 cKO and did not observe any major differences in number or 
morphology at embryonic stages.  
In summary, loss of Uhrf1 in the developing cortex leads to a late neurodegenerative phenotype 
wherein a majority of cortical neurons are lost in postnatal stages. Significant defects in radial glia 
and progenitor proliferation and differentiation were not observed (this study and Bayam. 2014). 
 
5.3. Transcriptional control of Uhrf1 in the embryonic cortex 
Transcriptional profiling of Uhrf1 cKO was performed to understand the molecular triggers of the 
cellular phenotype. This revealed that Uhrf1 is primarily involved in controlling cellular stress 
genes and retroviral elements. It is important to note that in support of our cellular phenotypic 
analysis, we did not observe transcriptional changes in cell fate genes such as Pax6, Ngn2 and 
Ascl1. Moreover, we also did not observe changes in genes related to self-renewal, also in 
concomitance to our phenotypic analysis. These data further indicate that loss of Uhrf1 does not 
trigger a change in neuronal fate. This is particularly in contrast to loss of Uhrf1 in HSCs, wherein 
KO cells exhibited deregulation of HSC self-renewal and differentiation genes (Zhao et al. 2016) 
and also its role in the zebrafish lens and T-regulatory cells (Tittle et al. 2011; Obata et al. 2014). 
These data suggest a highly cell-type specific role for Uhrf1. 
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Transcriptional profiling in E16 germinal zones (comprising mainly progenitors) primarily resulted 
in mild upregulation of interferon signaling and downregulation of oxidative phosphorylation 
genes. Surprisingly, transcriptional profiling in E16 progenitors and neurons did not uncover a 
change in interferon signaling but only that of oxidative phosphorylation. These data suggest that 
at E16, the neurons have still not activated interferon signaling and that it is largely present only 
in progenitors. Moreover, at postnatal day 5, interferon signaling is activated again, suggesting 
that by this time the neurons have also upregulated this pathway. In addition, P5 cKO cells also 
upregulated the unfolded protein response and downregulate genes expressed in adult mature 
neurons (LEIN_neuron markers). 
In general, three main pathways seem to be deregulated in the cKO – interferon signaling, 
oxidative phosphorylation and unfolded protein response. Each of these pathways have been 
known to cause cellular stress which could eventually lead to cell death, especially in 
neurodegenerative diseases (Johri and Beal 2012; Chen et al. 2014; Diaz-Castro et al. 2015; 
Pasquarella et al. 2016). Besides these pathways, we also observed genes related to germ-cells 
and x-linked genes to be upregulated. Similar groups of genes were also upregulated in the 
cerebral cortex Dnmt1 cKO (Hutnick et al. 2009), suggesting a link to DNA methylation changes. 
Interestingly, we could also detect some cell-cycle genes such as Cdkn1a and Cdkn1b to be 
mildly upregulated in the cKO. As mentioned previously, postmitotic neurons still express cell-
cycle related proteins after terminal neuron differentiation (Yoshikawa 2000) which is considered 
relevant for their terminal maturation. However, studies have shown that when neurons are 
subjected to certain injury or stress, such as oxidative stress for example, they upregulated certain 
cell-cycle proteins which in turn can cause a block at the G1/S cell cycle checkpoint, ultimately 
leading to their death (Frade and Ovejero-Benito 2015). Moreover, this type of cell cycle re-entry 
can also be observed in neurodegenerative diseases, wherein it can also lead to genome 
instability (Frade and Ovejero-Benito 2015). 
Uhrf1 possess E3 ligase activity which has been shown to be involved in the protein turnover of 
Promyelocytic leukemia protein (Pml) in primary human umbilical vein endothelial cells, HEK293 
and cancer cells (Guan et al. 2013). Therefore, we investigated if Uhrf1 could perform a similar 
function in the developing cerebral cortex. We assessed proteomic changes in controls and cKO 
at E16 and could identify a few upregulated and downregulated proteins in the cKO. In particular, 
we observed a 300 fold upregulation of the protein Nox3, a NADPH oxidase, in the cKO. Nox3 
belongs to the Nox family of genes, which contribute towards the production of reactive oxygen 
species. Increased ROS can lead to oxidative stress which has been described to be an 
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underlying mechanism of neurodegeneration (Gandhi and Abramov 2012). Thus, it is possible 
that Nox3 is contributing towards the cell death phenotype observed in the cerebral cortex Uhrf1 
cKO. 
Oxidative phosphorylation (OxPhos) is a metabolic process occurring in mitochondria, whereby 
energy is produced in an aerobic manner. Aberrations in this process can lead to the production 
of reactive oxygen species which can cause cellular stress and prove detrimental. In particular, 
production of ROS due to defects in oxidative phosphorylation can cause oxidative stress in 
neurodegenerative diseases such as Alzheimer’s disease, Amylotrophic Lateral Sclerosis, 
Huntington’s disease and Parkinson’s disease (Sayre et al. 2001). Conditional loss of SDHD in 
the neocortex, an important gene involved in mitochondrial function, resulted in a highly similar 
phenotype as that was observed here for Uhrf1 (Diaz-Castro et al. 2015). In particular SDHD cKO 
mice did not exhibit major defects in embryonic cortical neurogenesis or neurogenic cell fate and 
appeared largely normal until birth. However, they did display severe brain defects in later 
postnatal stages, with reduction in cortical tissue size, among other brain regions (Diaz-Castro et 
al. 2015). Moreover, our observed upregulation of Nox3 could be a function of the RING finger 
domain of Uhrf1, involved in protein turnover, exacerbating the defects in OxPhos and contributing 
towards oxidative stress. These data are consistent with our findings, suggesting that 
mitochondrial defects could prove more deleterious in postnatal cell types as compared to 
embryonic progenitors and neurons. 
Interferon signaling acts as an immune response against viral infections mediated by interferons. 
Interferons, which are cytokines, can be of different types such as interferon-α, interferon-β, 
interferon-α and others, each binding to specific receptors. Viruses often trigger interferon 
signaling via their dsRNA or viral proteins (Haller et al. 2006). Moreover, interferon signaling is 
crucial to combat viral infections as IFN-α,β knockout mice can quickly succumb to viral infections  
(Muller et al. 1994; Hwang et al. 1995; van den Broek et al. 1995; Grieder and Vogel 1999; Ryman 
et al. 2000; Bouloy et al. 2001; Bray 2001) Additionally, It has been shown that endogenous 
retroviral elements can trigger interferon signaling due to the presence of dsRNA from ERV 
activation (Chiappinelli et al. 2015). Interferon signaling can lead to cell death via apoptosis 
(Chawla-Sarkar et al. 2003).  
Unfolded protein response (UPR) is a cellular stress mechanism which occurs in response to an 
accumulation of misfolded proteins in the endoplasmic reticulum. This excess of protein load can 
often lead to cell death (Sano and Reed 2013). In fact, ER stress has been described to be an 
important contributor towards accumulation of β-amyloid plaques and α-synuclein leading to 
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neuronal death in the neurodegenerative Parkinson’s and Alzheimer’s disease (Sano and Reed 
2013). ER stress can also be triggered by endogenous retroviral elements which produce high 
levels of viral proteins, as has been shown for B-cells (Pasquarella et al. 2016). 
LEIN_neuron markers comprise those genes expressed in adult neurons and we observed many 
genes related to terminal neuronal differentiation to be underrepresented in the cKO. These data 
suggest that either the cKO neurons are hampered in their neuronal maturation processes which 
is consistent with persisting cell cycle gene expression or that the slight loss of neurons at this 
stage could be reflected with a transcriptional reduction in these genes. However, as we do not 
observe a significant difference in the cortical thickness at this stage, and we do not observe cell 
death as a clear deregulated pathway, we think it’s unlikely that a few less neurons in the cKO 
can be detected with a deregulated pathway. Thus, it is most likely that the postnatal neurons in 
the cKO are defective in their terminal differentiation and maturation processes.  
The transcriptional changes on coding genes were comparatively mild as compared to the major 
transcriptional changes observed on a set of RNA transposable elements, IAPs. IAPs, specific to 
the mouse genome, are a type of endogenous retroviral elements. Although we observed some 
individual LINE-1 and SINE-B1 elements (other ERVs) to be activated, the entire class was not 
significantly upregulated. We could observe about 25-30% of deregulated genes to be near 
activated IAPs. It has been shown that activated IAPs in proximity to genes can affect their nearby 
gene transcription (Fasching et al. 2015). Moreover, we also observed a major proportion of the 
individual activated LINE-1 elements to be in near activated IAPs. Thus, it is likely that the 
activated IAPs are regulating local transcription in the Uhrf1 cKO. 
Activation of transposable elements has been previously reported in knockouts of the DNA 
methylation machinery. Dnmt1 cKO of the developing cortex also led to a strong activation of IAP 
gag protein, however, the other REs were not analysed (Hutnick et al. 2009). Uhrf1 and Dnmt1 
KO ESCs significantly upregulate both IAPs and LINE element transcripts, with a higher activation 
in Dnmt1 KO (Sharif et al. 2007; Sharif et al. 2016). Conditional deletion of Uhrf1 at early 
development (about E9) in the whole embryo did not lead to a major increase in IAP and LINE 
activation, compared to a similar cKO of Dnmt1 (Sharif et al. 2016). These data indicate that loss 
of Uhrf1 could either be compensated for with regard to DNA methylation, or that Dnmt1 has other 
adapters for this process. Since we observe a strong activation of IAP in the developing cortex, 
which is not observed in the rest of the embryo, these data indicate a clear specificity for Uhrf1 in 
IAP regulation in the neocortex.  
Discussion 
 
98 
 
Besides proteins involved in the DNA methylation process, the histone methylation machinery 
has also been implicated in ERV regulation. Conditional loss of Setdb1 and Kap1, both involved 
in setting the H3K9me3 mark, in the neocortex led to IAP and other RE activation (Tan et al. 2012; 
Fasching et al. 2015). However, in both cases, the level of IAP activation was much lower than 
that observed in our Uhrf1 cKO. In both Setdb1 and Kap1 cKOs, H3K9me3 was reduced but DNA 
methylation was not altered significantly (Tan et al. 2012; Fasching et al. 2015). These data 
indicate that both DNA methylation and histone methylation can control ERV regulation. It remains 
to be elucidated if these machineries are exclusive or function together in such regulation. Uhrf1 
itself has been shown to bind both DNA and histones, providing a link between the two epigenetic 
pathways.  
We could observe that the activation of IAPs is sustained over a long period of time, wherein even 
weeks after Uhrf1 deletion, high levels of IAP mRNA and protein were detected in the postnatal 
cortical neurons, although Uhrf1 is not expression in these cells. Thus, IAP activation could not 
be re-silenced by other proteins and Dnmts/Tet enzymes expressed in cortical neurons. The 
implications of ERV activation in cellular process have largely been linked to being detrimental in 
nature. In general, ERVs have been heavily implicated in diseases such as cancers, neurological 
diseases and diabetes (Blomberg et al. 2000-2013). Overexpression of HERVK (a human ERV) 
in motor neurons causes neuronal death (Li et al. 2015). Moreover, this ERV has also been 
implicated in ALS, a neurodegenerative disease (Li et al. 2015). IAP activation has also been 
linked to cell death in primordial germ cells (Liu et al. 2014). 
In summary, we observed that Uhrf1 cKO exhibit early transcriptional changes which increase 
and accumulate into postnatal stages. Additionally, the cell death phenotype we detected is also 
progressive over time. We suggest two possible mechanisms which could cause this ‘late 
neurodegenerative phenotype’ – 1) a) The accumulation of deregulated genes and the nature of 
them causes the phenotype to deteriorate and 2) certain phenotypes are not deleterious at 
embryonic stages, but become critical at later stages when neurons mature and become 
functional. 
As discussed above, in support of our first theory, we observe activation of the OxPhos pathway 
in both progenitors and neurons, following which interferon signaling is activated (first in 
progenitors and then neurons) and finally UPR and a reduction in genes involved in neuronal 
maturation is detected (in postnatal neurons). Additionally, the IAP elements accumulate in all the 
cells as mRNA and protein, acting as possible cause and consequence of both the deregulated 
genes and subsequent cell death. Our second hypothesis stems from our finding that although 
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strong transcriptional changes are observed as early as E12, it takes several weeks for the cKO 
to exhibit a detrimental phenotype.  
 
5.4. Molecular mechanism of Uhrf1 in the developing neocortex  
The methylation changes we observed upon loss of Uhrf1 were broadly of two categories. In the 
first category, we observed that most of the loci which had lost methylation in the cKO, namely 
the differentially methylated promoters (DMRs), did not incur transcriptional changes. Some of 
the ERVs and other transposable elements such as LINE-1 and SINE-B1 also fell into this 
category. The second category comprised mainly of the IAP family of ERVs which had both lost 
methylation and had upregulated transcripts in the cKO. Thus, our two main conclusions from 
these data are that – 1) Uhrf1 has a great deal of specificity in regulating methylation of its target 
loci and 2) Loss of methylation does not have to be a necessary trigger for transcriptional 
activation in the developing neocortex.  
Global methylation was analyzed by immunostaining, DNA restriction digests and RRBS and 
indicated that about 50% of the genome lost methylation upon Uhrf1 deletion in the developing 
cortex. The data from the DNA restriction digests with HpaII indicated that there was higher levels 
of demethylation in the cKO at E16, which is in accordance with the immunostainings. Loss of 
Uhrf1 in ES cells and the zebrafish lens also resulted in hypomethylation with restriction digets 
(Tittle et al. 2011; Sharif et al. 2007). From the immunostainings for 5mC at E14, we observed a 
severe reduction of 5mC in the cKO cerebral cortex. However, some cells still retained 5mC upon 
Uhrf1 deletion. Some of these remaining cells colocalized with Pax6, Tbr2 and Tuj1. These cells 
could have arisen from radial glia prior to Cre recombination and Uhrf1 loss, however this is 
probably unlikely as the Emx1 recombination occurs prior to neurogenesis. Some of 5mC positive 
cells in the cKO did colocalise with Calbindin-interneurons (data not shown) which would arise 
from the GE where Uhrf1 is not deleted, and migrate into the cortex. We could also detect the 
ectopic 5hmC in the cKO at E14, which increased at E16 in the germinal zones of the cKO cortex. 
We did not observe ectopic 5hmC at E12 in the cKO, although we already detected some IAP 
transcript activation. Thus, it could be that E12 is the onset of IAP activation in the cKO, with some 
low levels of 5hmC which cannot yet be detect by immunostaining. At E14 and E16, the level of 
IAP activation increases greatly, along with the presence of 5hmC positive cells in the cKO.  
In fact, a study wherein G9a was also deleted in the neocortex with Emx1-Cre, the loss of 
H3K9me2 observed was in a highly similar pattern to the reduced 5mC levels in our Uhrf1 cKO 
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(Kumar. 2013) The cells which had retained H3K9me2 upon G9a deletion were in a similar 
distribution as those cells which retained 5mC after Uhrf1 deletion, at E14. As mentioned before, 
G9a is a histone methyltransferase which can bind Uhrf1. It is interesting to speculate that these 
two molecules could be working in conjunction in cortical radial glia.  
The RRBS analysis uncovered specific loci in the genome which had lost methylation in the cKO. 
Firstly, it revealed that on every chromosome of the cKO, about 40-60% of loci had lost at least 
25% of 5mC compared to controls. This data indicates that Uhrf1 has a wide range of target loci, 
but that it is not required for methylation of all the loci. The remaining loci which have retained 
methylation could be regulated by other factors, either acting in conjunction with Dnmt1 or 
Dnmt3a/b. There could also be compensation by another factor on loss of Uhrf1. Although Uhrf2 
an also bind DNA, there have been no reports yet of its expression in neural stem cells. It is also 
important to note that the RRBS analysis was carried out on the entire cortical tissue, comprising 
radial glia, progenitors and neurons. Thus, we cannot ascertain which loci are methylated in which 
cell types. Therefore, it is possible that the loci which lost methylation in the cKO are specifically 
methylated only in proliferating cells and were thus affected when Uhrf1 was deleted. Further 
analysis using pure cell populations can shed light on these points.  
Loss of Uhrf1 in the developing cortex led to 850 loci losing at least 25% of 5mC at E16. We could 
not align these 850 regions with a specific pathway or cellular mechanism, suggesting a random 
function for Uhrf1 in gene silencing in the neocortex. This finding contrasts slightly with the HSC 
system, wherein loss of Uhrf1 led to loss of methylation on specific loci related to self-renewal 
and HSC differentiation, which reflected the cellular phenotype (Zhao et al. 2016). Also, loss of 
Uhrf1 in regulatory T-cells lead to derepression of p27kip1, a cell cycle regulator which in turn 
caused defects in T-cell proliferation (Obata et al. 2014). Thus, although the DNA methylation 
function of Uhrf1 is retained in the cerebral cortex, its target genes vary, thus affecting different 
cellular processes. 
From the 850 affected loci in the cKO, only 4 genes had upregulated transcripts at E16, from the 
full cortex RNAseq data. These data clearly suggest that loss of 5mC is not sufficient for 
transcriptional activation in the developing cerebral cortex. There is evidence from literature which 
suggests that promoter methylation can regulate transcription directly or that additional layers of 
regulation such as histone marks might be necessary to regulate transcription from loci (Hackett 
and Surani 2013). 
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In addition to these 850 loci, we also observed many transposable elements to lose methylation 
in the cKO. In particular, we observed about 35% loss of 5mC on all IAPs, LINE and SINE 
elements. The loss of 5mC on IAP and LINE-1 was further confirmed with OxBS coupled with 
miSeq on specific CpGs on IAP Gag region and LINE-1 ORF1. Loss of methylation on repeat 
elements has also been reported for the Dnmt1 cKO of the cerebral cortex (Hutnick et al. 2009). 
The rather surprising finding in our methylation data was the ectopic increase in 5hmC in Uhrf1 
cKO. This result has not been previously reported in a Dnmt1 knockout or Uhrf1 knockout of 
another system. Reports have claimed that Uhrf1 can bind to 5hmC (Frauer et al. 2011; Spruijt et 
al. 2013). However, there is also a study claiming that Uhrf1 only binds 5mC and not 5hmC 
(Hashimoto et al. 2008). We observed a clear increase in 5hmC only from E14 at the level of 
immunostaining, which is after IAP is activated on mRNA. It is possible that 5hmC is increased 
on IAP also at E12, especially since we observed their transcriptional activation at this stage. 
However, it could also be that loss of 5mC leads to slight IAP transcriptional activation, which 
further exacerbates due to the accumulation of 5hmC. Ours and data from the literature is still 
preliminary to understand the exact dynamics of loss of 5mC and 5hmC in Uhrf1 cKO.  
To identify the specific loci with increased 5hmC in the cKO, we performed 5hmeDIP in E16 
germinal zones. The reason we excluded the cortical plate is because the control cortex also 
contains high levels of 5hmC in this region (Hahn et al. 2013). 5hmeDIP relies on enriching the 
levels of 5hmC but it is not an absolute quantitative technique, as compared to RRBS. Thus, it is 
less sensitive in its detection of changes of 5hmC in a sample. Nevertheless, we could identify a 
significant increase of 5hmC on IAPs in the cKO compared to the control. The increase was 
primarily on the Gag and LTR region of IAP. The LTR region can act as the promoter of the IAP, 
and thus this accumulation could potentially facilitate binding of transcription factors to the LTR to 
activate its transcription. Moreover, in the Gag region, the increased 5hmC was specific to a 
region called SHIN, which is a small sequence capable of inducing heterochromatin in ESCs 
(Sadic et al. 2015). Demethylation of this region could reduce levels of heterochromatin, allowing 
transcription. In fact, increased 5hmC levels have been described to lead to transcriptional 
activation (Wu et al. 2011). 
In order to obtain a better understanding of the absolute levels of 5hmC, among all CpGs on IAPs, 
we utilized the OxBS-miSeq data. In this experiment, we could deduce levels of 5hmC in control 
and cKO cerebral cortices at E16. We could only see a 1.6% increase in 5hmC on IAP and 0.4% 
for LINE-1 in the cKO compared to the control. Thus, the 5hmeDIP and miSeq data in conjunction 
revealed that although there is a significant increase in 5hmC on IAP, the absolute levels of 5hmC 
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are quite low. Due to this reason, it might be that other genes and loci have also increased 5hmC 
on the cKO, however, we may have missed this change with 5hmeDIP. Thus, further genome 
wide deep sequencing such as TAB-seq (Tet assisted BS) might shed more light on this point. 
Our working hypothesis for IAP regulation from the above data was that loss of Uhrf1 could lead 
to increased access for Tet enzymes to convert existing 5mC to 5hmC. Since we did not observe 
an increase in Tet mRNA in the cKO, we concluded that the levels of Tet are unaltered. Thus, 
Uhrf1 and Tet could compete for the IAP locus to regulate its transcription. We tested this 
hypothesis in vivo by employing in utero electroporation of the developing cerebral cortex (Saito 
et al. 2005; Stahl et al. 2013). Tet2 and Tet3 have been described to be expressed highly in the 
embryonic cerebral cortex compared to Tet1 (Hahn et al. 2013). Thus, we employed Scrambled, 
Tet2 and Tet3 shRNAs from this. We electroporated a Tet2/3 shRNA cocktail into cKO embryos 
at E13 and analysed the GFP+ve and GFP-ve cells for IAP mRNA. We could observe a significant 
reduction of IAP mRNA in GFP+ve cells compared to the surrounding GFP-ve cells for each 
analysed cKO embryo. These data suggested that downregulating Tet enzymes could alleviate 
some of the IAP activation in the cKO.  
We deduced that this action of Tet enzymes probably occurs in the radial glia stage, since Uhrf1 
is expressed in these cells and IAP regulation should occur in them. It would also be interesting 
to understand if Uhrf1 directly binds to IAP and other REs in the developing cortex. It has been 
shown in ESCs that both Dnmt1 and Uhrf1 can bind the IAP locus (Sharif et al. 2016). 
Thus, we decided to focus on the NSCs or radial glia to investigate and strengthen our in vivo Tet 
data. We generated an in vitro NSC system to delete Uhrf1 wherein several molecular aspects of 
the in vivo data could be recapitulated here. We observed activation of IAPs, with no significant 
change in LINE-1 and SINE-B1 mRNA. We analyzed methylation with immunostainings and 
OxBs-miSeq and observed a significant reduction of 5mC in the Cre treated cells. Importantly, 
from the OxBs-miSeq experiment, we detected an increase of about 3.8% in 5hmC on IAP 
compared to a 0.2% increase on LINE-1. Although we could observe a trend for increased 
Annexin V staining in the Cre treated cells, the increase was not significant due to high variability 
between replicates. It could be that the passage number affects the level of cell death in these 
NSCs as they are quite vulnerable compared to immortalized cell lines. We employed the same 
shRNAs for Tet2/3 and Scrambled in this NSC system. In accordance with our in vivo data, we 
observed that NSCs deleted for Uhrf1 with Tet2/3 knockdown had a significantly lower level of 
IAP activation to those only deleted for Uhrf1.  
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In summary, our data strongly suggest that in the absence of Uhrf1 in cortical radial glia, Tet 
enzymes are playing a key role in IAP activation, probably by increasing 5hmC levels on these 
elements, which can allow key transcription factors to drive transcription from these loci. In 
physiological conditions, where Uhrf1 is present in radial glia, Tet might be spatially blocked from 
binding IAP and regulating 5hmC levels and thus its transcription. This in turn keeps IAP elements 
silenced. 
 
5.5. Uhrf1 function in adult neurogenesis 
Uhrf1 is expressed by a small proportion of adult NSCs, most of the TAPs and some neuroblasts 
in the adult SEZ (Bayam. 2014). In the dentate gyrus, Uhrf1 is expressed by TAPs and some 
neuroblasts as well. However, in both OB neurons and hippocampus neurons, Uhrf1 protein is 
not detected (Bayam. 2014). Thus, in contrast to the embryonic cortex, Uhrf1 is expressed mainly 
by TAPs in the adult neurogenic niches. Conditional deletion of Uhrf1 in adult NSCs using Glast-
CreERT2; Uhrf1 flox; CAG mice, led to clear defects in proliferation and differentiation (Bayam. 
2014). In Uhrf1 adult cKO, Ki67+ve cells (labelling proliferating TAPs and neuroblasts primarily) 
were significantly reduced in both the SEZ and DG (Bayam. 2014). Moreover, recombined cells 
were generally reduced as well as neuroblasts in both the SEZ and DG (Bayam. 2014). We 
investigated mitotic cells in the SEZ and could observe a reduction of pH3+ve cells in the adult 
SEZ cKO. These defects in proliferation are in accordance with other studies wherein Uhrf1 was 
deleted in non-cancer cell types and cell cycle defects were observed (Bonapace et al. 2002; 
Arima et al. 2004; Sadler et al. 2007; Tittle et al. 2011) but in contrast to our data in the developing 
cerebral cortex. 
A reduction in recombined cells could be due to either a reduced generation of TAPs and 
neuroblasts (via aberrant proliferation) or due to increased cell death. We investigated cell death 
with TUNEL assay and could not observe a significant upregulation of TUNEL in the cKO. Thus, 
we favor the hypothesis that in the adult cKO, proliferation is hampered leading to fewer TAPs 
and neuroblasts. Interestingly, this reduction of neuroblasts in the SEZ does not affect the number 
of OB neurons in the cKO. This could suggest compensation by the SEZ-OB system to ensure 
more neuroblasts survive in the OB and mature into neurons. This feature has been previously 
reported for the SEZ and OB (Petreanu and Alvarez-Buylla 2002; Mouret et al. 2008; Mouret et 
al. 2009). 
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Although Dnmt1 has not been studied in the adult neurogenic niches, Dnmt3a is expressed in the 
postnatal SEZ and DG (Feng et al. 2005; Feng et al. 2010; Wu et al. 2010). As mentioned 
previously, Uhrf1 can also bind Dnmt3a (Meilinger et al. 2009). In fact, Dnmt3a null mice display 
defects in both SEZ and DG neurogenesis which are similar to those observed in the adult Uhrf1 
cKO (Wu et al. 2010) (Bayam. 2014). The underlying mechanism was uncovered to be related to 
DNA methylation wherein Dnmt3a was shown to methylate promoters of gliogenic genes and 
genes bodies of neurogenic genes (Wu et al. 2010). It is likely that in our Uhrf1 cKO, the 
methylation of these regions is similarly affected, resulting in neurogenic defects. Another 
molecule which Uhrf1 binds, namely HDAC1 (Unoki et al. 2004), has also been implicated in SEZ 
neurogenesis. HDAC1 is expressed by GFAP+ve cells which comprise of aNSCs in the postnatal 
SEZ and inhibitors against HDAC1 and 2 reduced SEZ neurosphere formation (MacDonald and 
Roskams 2008; Montgomery et al. 2009; Zhou et al. 2011; Foti et al. 2013). 
Although we could not ascertain a clear change in methylation, we examined IAP gag 
immunostaining in the SEZ and DG. To our surprise, although IAP is activated in the adult SEZ 
cKO, we did not observe this activation in the adult DG cKO. These data further describe a cell-
type specific role for Uhrf1 in IAP regulation.  
In summary, Uhrf1 plays a more conventional role in adult neurogenesis, affecting progenitor 
proliferation and neurogenesis, similar to that observed in other cellular systems. This contrasts 
with our embryonic findings, clearly exhibiting different roles for Uhrf1 in embryonic and adult 
neurogenesis. 
 
5.6. Conclusions and prospects 
Our study has introduced Uhrf1 to be an important epigenetic player in cortical and adult 
neurogenesis. Conditional deletion of Uhrf1 elucidated a unique function of Uhrf1 in ensuring 
appropriate postnatal cortical neuron numbers. In general, we detected a ‘late neurodegenerative’ 
phenotype which has not been observed previously for transcription factor or cell cycle regulators. 
This finding has elucidated a new type of transcriptional control wherein early molecular programs 
in radial glia can play critical roles in later stages of the neurogenic process, such as in terminal 
differentiation and maturation and neuronal survival. Our findings are supported by data from 
Dnmt loss of function of studies wherein Dnmt1 and Dnmt3a were deleted in either radial glia or 
only in neurons. Only loss of Dnmt1 in progenitors affected neuronal survival (Hutnick et al. 2009), 
whereas loss of Dnmt1 and Dnmt3a in postmitotic neurons did not affect neuronal survival (Feng 
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et al. 2010). Thus, there is strong evidence that this type of transcriptional control is related to the 
DNA methylation maintenance function of Uhrf1. 
Moreover, our data have implicated a critical role for the maintenance of DNA methylation on 
retroviral elements, IAPs, in this above process. We have uncovered a layer of specificity in the 
regulation of transposable elements, in this case Uhrf1 for IAP. Although Uhrf1 does regulate IAP, 
this process is also not ubiquitous to every cell as was observed in the adult DG and in the early 
conditional deletion of the whole embryo (Sharif et al. 2016). Another crucial finding in our study 
was the lack of correlation between DNA methylation and transcription, strongly suggesting that 
loss of 5mC is not deterministic for transcriptional activation. Additional mechanisms are 
necessary in order to allow transcription from highly methylated and silenced loci, which in our 
case was observed to be Tet regulated 5hmC production.  
Our differences in Uhrf1 phenotypes in the embryo and adult indicate a cell-type specific role for 
this protein. Although expressed by proliferating cells in all tissues studied till date, it does not 
appear to always control self-renewal and differentiation. It would be interesting to study the role 
of Uhrf1 in the context of reprogramming and neuronal injury, to further understand the multiple 
mechanisms of this protein. In fact, Uhrf1 has been reported to be upregulated in cortical injury 
(Bayam. 2014). 
Our study has generated several interesting and important future directions. Firstly, the underlying 
mechanism of the adult cKO should be understood to elucidate if DNA methylation is impaired 
and which genes are transcriptionally altered. It would be important to look at 5hmC in this system 
and investigate if the Tet competition would exist here as well.  
Secondly, additional experiments towards a better understanding of 5hmC and Tet/Uhrf1 interplay 
is quite crucial. 5hmC levels can be analysed in the Dnmt1 cKO of the cerebral cortex and of 
Uhrf1/Dnmt1 KO ESCs.  Furthermore, next generation deep sequencing coupled with TABseq 
can be carried out to assess the exact levels of 5hmC in the Uhrf1 cortical cKO, especially on 
coding genes. Moreover, ChIP-seq experiments for Uhrf1 and Tet in this system would add 
relevant information on the binding sites of these proteins - which genes and transposable 
elements.  
Thirdly, the implication of IAP activation on cellular processes can be studied more extensively. It 
would be useful to perform next generation sequencing of cKO DNA with high coverage to 
discover if IAP transcriptional activation can also lead to its transposition. Moreover, tools such 
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as CRISPR can be used to manipulate individual IAP elements and study the resulting 
phenotypes, if they lead to neurodegeneration for example.  
In general, our study has enlightened the unique mechanisms of epigenetic players in 
neurogenesis. Further studies examining other epigenetic modifications and relevant proteins 
would provide us with important answers towards understanding the key molecular mechanisms 
of neurogenesis, which is crucial for steps towards neuronal repair. 
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6. Materials and Methods  
 
6.1 Materials 
6.1.1 Chemicals       
 
Chemical 
 
Company 
 
Acetic Acid 
Actinomycin D 
Acrylamide/Bis solution 
 
Merck 
Sigma 
Sigma 
Agarose 
Ammonium persulfate (APS) 
Biozym 
Thermo Fisher Scientific 
Ampicillin Roth 
Aqua Poly / Mount 
Corn oil 
Chloroform 
Polyscience Inc. 
Sigma 
Sigma 
DAPI (4,6-dasmindino-2-phenylindol) AppliChem 
Difco LB-Agar Hartenstein Labor. 
DNA Ladder (Generuler 1kb) Fermentas 
EDTA Merck 
Ethanol 
Fast Green 
Merck 
Sigma 
Glycerol 
Glycine 
Sigma 
Sigma 
HEPES Roth 
Hydrochloric acid Merck 
Isopropanol 
Methanol  
Merck 
Merck 
Normal goat serum (NGS) Vector Lab. 
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Orange G Sigma 
Paraformaldehyde (PFA) Merck 
PCR buffer (10X Taq Buffer) Qiagen 
PCR dNTP Mix (25mM each) Fermentas 
PCR reagent: MgCl2 (25mM) 
Potassium chloride 
Potassium phosphate monobasic 
Potassium perruthanate 
Phenol:Chloroform:Isoamyl alcohol 
Pierce ECL western blotting substrate 
Qiagen 
Sigma 
Sigma 
Sigma 
Thermo Fisher Scientific 
Thermo Fisher Scientific 
PMSF Thermo Fisher Scientific 
COmplete, Protease inhibitor cocktail Roche 
Proteinase K 
Q solution 
Roth 
Qiagen 
QIAzol 
RNase-free DNase 
Sodium acetate 
Invitrogen 
Qiagen 
Sigma 
Sodium chloride Fisher Bioreagents 
Sodium citrate Merck 
Sodium dodecyl sulphate (SDS) Roth 
Sodium phosphate monobasic Sigma 
Sodium phosphate dibasic Sigma 
Sodium hydroxide 
SYBR green 
SYBR safe DNA gel stain 
Tamoxifen 
Roth 
Qiagen 
Thermo Fisher Scientific 
Sigma 
Taq DNA Polymerase 
TEMED 
Qiagen 
Sigma 
Tissue Tek Hartenstein Labor. 
Tris Base Sigma 
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6.1.2 Tissue Culture Reagents        
  
Tris-HCl Sigma 
Trizma acetate Sigma 
Triton-X-100 Roth 
Tween-20 Sigma 
 
Chemical 
 
Company 
 
B-27 Serum-Free Supplement 
 
Thermo Fisher Scientific 
Cre recombinant protein Synthesized by Arie Geerdof at the   
Helmholtz Zentrum 
DMEM:F12 (Dulbecco's Modified Eagel 
Medium:Nutrient Mixture F12)+ GlutaMAX 
Thermo Fisher Scientific 
DMSO Sigma 
EGF (Epidermal Growth Factor) Roche 
FGF2 (Fibroblast Growth Factor-2) Roche 
HBSS 1X (Hank's balanced salt solution) Thermo Fisher Scientific 
HBSS 10X Thermo Fisher Scientific 
HEPES (1M) 
N2 supplement 
Thermo Fisher Scientific 
Thermo Fisher Scientific 
Penicillin/Streptomycin (Pen/Strep) Thermo Fisher Scientific 
Poly-D-Lysine (PDL) Sigma 
Poly L-Ornithine Sigma 
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6.1.3 Standard Solutions and Buffers 
 
Phosphate Buffer Saline (PBS) (0.15M) 
137 mM NaCl  
27 mM KCl  
83 mM Na2HPO4  
15 mM KH2PO4  
pH 7.4 
 
Paraformaldehyde (PFA) 4%  
To prepare 4% PFA, 40 g of PFA was dissolved in 800ml MilliQ water with gentle heating whilst 
stirring. 3 NaOH pellets were added to aid the PFA to go into solution and dissolve. The solution 
was cooled down to room temperature and HCl was added slowly till the pH dropped dramatically 
between pH 1-3. The pH was then adjusted to 7.2 -7.3 with 100 ml of 10X PBS and the solution 
was made upto 1 litre with MilliQ water. The solution was then filtered through a paper filter and 
stored at 4°C. 
 
Lysis Buffer for tail DNA extraction 
100mM Tris, pH8.0-8.5 
200mM  NaCl 
5mM  EDTA, pH8.0 
2%  SDS    
Trypan Blue Thermo Fisher Scientific 
Trypsin (EDTA), 0.05% Thermo Fisher Scientific 
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50X TAE Buffer 
2 M Tris Acetate 
50 mM EDTA  
Adjust pH 8.0 with Acetic Acid 
 
Western blotting 1X Running Buffer 
25 mM Tris-base 
192 mM Glycine 
0.1 % SDS 
 
Western blotting 1X transfer buffer 
192 mM Glycine 
25 mM Tris-Base,  
20 % Methanol 
 
Nuclear/cytoplasmic protein extraction - Tween lysis buffer 
25 mM Tris or Hepes,pH 8.0 
20m mM NaCl 
2 mM EDTA 
1 mM phenylmethylsulfonyl fluoride (PMSF) 
 0.5% Tween 20 
Add Roche protease inhibitor cocktail just before use 
 
5hmeDIP - DNA Lysis buffer:                                                          
50mM tris pH 8.0                                                            
0.5% SDS                                                                           
0.5mM EDTA pH 8.0 
Materials and Methods 
 
112 
 
5hmeDIP - IP buffer                                                                         
100mM sodium phosphate pH 7 
1.4M NaCl                                                                         
0.5% Triton X 
 
5hmeDIP - 1M Sodium phosphate buffer 
2M monobasic sodium phosphate 
2M dibasic sodium phosphate 
pH 7 
 
5hmeDIP - TE (Tris-EDTA) buffer 
10mM Tris-HCl pH 8.0 
1mM EDTA pH 8.0 
 
6.1.4 Cell Culture media 
Dissection medium  
 
Add 5 ml of HEPES 1 M (final concentration 10 mM) to 500 ml of HBSS 1X 
 
NS cell proliferation medium 
 
To DMEM F-12 media with Glutamax add 1% Penicillin/Streptomycin, B27 and N2 supplement. 
Before use, add EGF and FGF. 
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6.1.5 Kits 
 
Name 
 
Company 
 
RNeasy Mini Kit 
 
Qiagen 
Qiagen plasmid Maxi kit Qiagen 
Gel Extraction Kit Qiagen 
NEBNext Ultra Directional RNA library prep 
kit for Illumina  
NEB 
NEBNext Ultra DNA library prep kit for 
Illumina 
NEB 
NEBNext Multiplex oligos for Illumina NEB 
EZ DNA methylation-gold kit Zymo research 
DNeasy blood and tissue extraction kit Qiagen 
Picopure RNA isolation kit 
EpiJET DNA methylation analysis kit 
Ribozero gold rRNA removal kit 
(Human/mouse/rat)  
SMARTer Stranded Total RNA Sample Prep 
Kit - Low Input Mammalian 
Ribogone – Mammalian kit 
Apoptag Red In Situ Apoptosis detection kit 
Thermo Fisher scientific 
Thermo Fisher Scientific 
Illumina 
 
Clontech 
Clontech 
Millipore 
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6.1.6 Antibodies  
6.1.6.1 Primary Antibodies  
 
Antigen  (species) 
 
Working Dilution 
 
Company 
 
Anti-5mC (mIgG1) 
 
1:1000 
 
Millipore 
Anti-5hmC (rabbit) 1:1000 Active motif 
Anti-β- tubulin-III (mouse, IgG2b) 1:500 Sigma Aldrich 
Anti-Ctip2 (rat) 1:200 Abcam 
Anti-Gfap (rabbit) 1:200 DAKO 
Anti-Gfap (mouse, IgG1) 1:200 Sigma 
Anti-GFP (chicken) 1:800 Aves Labs 
Anti-Histone H3 (rabbit) 1:1000 Abcam 
Anti-IAP (rabbit) 1:1000 Kind gift from Dr. Cullen 
Anti-Iba1 (rabbit) 1:500 Wako 
Anti-Ki67 (rat) 1:200 Thermo Scientific 
Anti-Ki67 (rabbit) 1:200 eBioscience 
Anti-NeuN (mouse, IgG1) 1:100 Millipore 
Anti-Olig2 (rabbit) 
Anti-Pax6 (rabbit) 
1:500 
1:200 
Millipore 
Millipore 
Anti-pH3 (rabbit) 1:500 Millipore 
Anti –Tbr1 (rabbit) 1:200 Abcam 
Anti –Tbr2 (rabbit) 1:200 Abcam 
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Anti Uhrf1 ( rabbit ) 1:1000 Kind gift from 
I.M. Bonapace 
 
6.1.6.2 Secondary Antibodies  
 
Antigen  (species) 
 
Working Dilution 
 
Company 
Anti rabbit Alexa488 ,546 ,633 1:1000 Invitrogen 
Anti chick Alexa 488 1:1000 Invitrogen 
Anti rat 488, 546 1:1000 Invitrogen 
Anti-mouse IgG1 Alexa 488,546,633 1:1000 Invitrogen 
Anti-mouse IgG2b Alexa546 , 633 
Anti-guinea pig 633 
1:1000 
1:1000 
Invitrogen 
Thermo Fisher Scientific 
Anti-rabbit, HRP 1:25,000 Thermo Fisher Scientific 
Anti-mouse IgG, HRP 1:20,000 Thermo Fisher Scientific 
 
6.1.7 Primers  
6.1.7.1 Genotyping Primers  
 
Name 
 
Sequence 5´-3´ 
Glast for 
Glast rev 
CER1(CreERT2 specific) 
GAGGCACTTGG TAGGCTCTG AGGA 
GAGGAGATCCTGACCGATCAGTTGG 
GGTGTACGGTCAGTAAATTGGACAT 
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Emx1 for 
Emx1 rev 
Cre 
GTGAGTGCATGTGCCAGGCTTG 
TGGGGTGAGGATAGTTGAGCGC 
GCGGCATAACCAGTGAAACAGC 
Uhrf1 for 
Uhrf1 rev 
ACCACATCACTCTTGATCTGTGCC 
GGATGTTAGGTGTGAGCCACCATG 
 
CAG for 
CAG rev 
CTG CTA ACC ATG TTC ATG CC 
GGT ACA TTG AGC AAC TGA CTG 
 
6.1.7.2 RT-qPCR Primers  
 
Primer name 
 
Sequence 
 
Reference 
 
IAP-5'UTR-F CGGGTCGCGGTAATAAAGGT (Rowe et al. 2010) 
IAP-5'UTR-R ACTCTCGTTCCCCAGCTGAA  
LINE-1-ORF1-F GAACCAAGACCACTCACCATCA (Vitullo et al. 2012) 
LINE-1-ORF1-R CCCTGGACTGGGCGAAGT  
SINE-B1-F TGGCGCACGCCTTTAATC (Gualtieri et al. 2013) 
SINE-B1-R TGGCCTCGAACTCAGAATCC  
Uhrf1-F AAACGCCCTGAGTTTTCGC Designed in this work 
Uhrf1-R GCCGATGTACTCTCTCACG  
Gapdh - F ATTCAACGGCACAGTCAAGG Designed in our lab 
Gapdh - R TGGATGCAGGGATGATGTTC  
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6.1.7.3 Bisulfite sequencing primers  
 
Primer name 
 
Sequence 
 
Reference 
 
IAP-Gag-F AGGTTAGTTTGTTGATTGGTTTTAG (Sadic et al. 2015) 
IAP-Gag-R AATCAACAAAATAAACTCCCTAACC  
LINE-1-F GTTAGAGGATTTGATAGTTTTTGGAATAGG (Tommasi et al. 2012) 
LINE-1-R CCAAAACAAAACCTTTCTCAAACACTATAT  
 
6.1.7.4 ChIP primers  
 
Primer name 
 
Sequence 
 
Reference 
 
Polrmt-F TCAGCAAACTCCAATAGCGCAC (Bilodeau et al. 2009) 
Polrmt-R TTGCCGCACAACATGGACTT  
Gapdh-F CTCTGCTCCTCCCTGTTCC (Jörg Tost  2009) 
Gapdh-R TCCCTAGACCCGTACAGTGC  
LINE - 1 ORF2-F TTTGGGACACAATGAAAGCA Designed in Schotta lab 
LINE - 1 ORF2-R CTGCCGTCTACTCCTCTTGG  
SINE-B1-F GTGGCGCACGCCTTTAATC Designed in Schotta lab 
SINE-B1-R GACAGGGTTTCTCTGTGTAG  
IAP-5’UTR-F CGGGTCGCGGTAATAAAGGT (Rowe et al. 2010) 
IAP-5’UTR-R ACTCTCGTTCCCCAGCTGAA  
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6.1.8 Constructs 
The Tet2, Tet3 and Scrambled shRNA constructs were kindly provided by Dr. Qiang Lu at the 
Beckmann Research Institute (USA) (Hahn et al. 2013) 
 
6.2 Methods 
6.2.1 In vivo Methods 
6.2.1.1 Mouse lines  
All the animals used for the experiments were kept at the in the animal facility of the Helmholtz 
Zentrum München on a 12h light-dark cycle. All the animal procedures were performed in 
accordance with German and European Union guidelines. Adult animals were used at the age of 
2-3 months and embryonic animals were used at the indicated embryonic day where day of 
vaginal plug was considered to be embryonic day 0 (E0)  
 
Strain   Characteristics Producer 
Emx1Cre This line expresses Cre recombinase from the 
endogenous Emx1 locus. 
Iwasato et al.2000 
 
CAG CAT eGFP The CAG CAT GFP reporter line contained 
CMV-β actin promoter and loxP flanked CAT 
gene upstream of the enhanced green 
fluorescent protein (eGFP) cassette. With Cre 
excision, the GFP is expressed. 
Nakamura et al 2006 
GlastCreERT2 The GLAST::CreERT2 mouse line contains 
the inducible form of Cre (CreERT2) in the 
astrocyte specific glutamate transporter 
(GLAST) locus. In this line, Cre is fused to the 
ligand binding domain of the modified 
estrogen receptor (ERT2), thus it is restricted 
to the cytoplasm. Upon Tamoxifen induction, 
Mori et al 2006 
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the Cre can translocate to the nucleus and 
carry out excision and recombination.    
Uhrf1tm1a(EUCOMM)Wtsi The Uhrf1tm1a(EUCOMM)Wtsi mouse line was 
generated by EUCOMM by using 
promoterless targeting cassettes for the 
generation of knockout-first alleles (Skarnes 
et al., 2011). A critical exon is identified such 
that when it is deleted, a frame shift mutation 
is created which in turn causes nonsense 
mediated decay of the corresponding 
transcript. The exon chosen is common to all 
transcript variants of that gene. 
EUCOMM 
 
6.2.1.2 Anesthesia and Perfusion 
For perfusion, animals were anesthetized by intraperitoneal injection of Ketamin 
(Ketaminhydrochlorid, 100mg per kg of body weight) and Rompun (Xylazinhydrochlorid, 20mg 
per kg of body weight) prepared in 0,9 % NaCl solution (Braun). Then they were transcardially 
perfused first with a preflush of PBS followed by 4 % PFA in PBS. The brains were then removed 
and post fixed in 4 % PFA overnight. 
 
6.2.1.3 In utero electroporation 
Animals were operated as approved by the Government of Upper Bavaria. E13.5 timed pregnant 
mice were anaesthetized by intra-peritoneal (i.p.) injection of Fentanyl (0.05mg/kg), Midazolam 
(5mg/kg) and Medetomidine (0.5mg/kg). Plasmids used were Scrambled, Tet2 and Tet3 shRNA 
kindly provided by Professor Qiang Lu at the Beckmann research institute, USA (Hahn et al. 
2013). In utero electroporation was done as described earlier (Saito, 2006). Briefly, pregnant mice 
were anesthetized placed on heated pads to keep warm. The shaved abdomen was opened to 
expose the uterine horns, which were kept moist by pre-warmed saline. Plasmids were mixed 
with Fast Green (2.5mg/µl, Sigma) and injected at a concentration of 1 µg/µl into the ventricles of 
the embryos, using glass capillaries. An electrical pulse was applied to direct the DNA towards 
the dorsal telencephalon, 4 pulses of 33mV and 100ms. The embryos were replaced into the 
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uterus which is then sewn together using surgical sutures. Anesthesia was terminated by 
subcutaneous injection of Buprenorphine (0.1mg/kg), Atipamezol (2.5mg/kg), Flumazenil 
(0.5mg/kg) and the animals were monitored as they woke up. At E16, the pregnant mother was 
sacrificed and the embryos were obtained for further analysis. 
 
6.2.1.4 Tamoxifen Treatment  
Tamoxifen was dissolved in pre-warmed corn oil at a concentration of 20mg/ml by sonicating it 
for 15 min. 50µl of tamoxifen was injected intraperitoneally twice a day for 5 consecutive days to 
achieve efficient recombination in mice carrying the GlastCreERT2 allele. Tamoxifen was stored at 
4ºC for a maximum time of 1 month to avoid precipitation. 
 
6.2.2 Methods in Cell Biology 
6.2.2.1 Dissection 
Embryos harvested from pregnant mothers or postnatal pups which had been perfused were 
dissected for the brain. The embryonic brains were fixed either for 2 hours (E12), 3 hours (E14), 
4 hours (E16) or overnight (E18 or postnatal) in 4% PFA. Brains dissected from perfused pups 
were post-fixed for 1 hour in 4% PFA. Following fixation, the brains were washed 2 times in PBS. 
For RNA and DNA extraction, cerebral cortices were dissected from embryonic and postnatal 
brains. For the E16 germinal zones RNAseq, the cerebral cortex was further dissected for the 
germinal zones by first sectioning with the tissue chopper at 300µm thickness. These slices were 
then cut into half with the lower part being considered as the germinal zones. For RNA, the tissue 
was dissolved in QIAzol and for DNA the tissue was snap frozen in liquid nitrogen. 
 
6.2.2.2 Tissue Preparation  
For embryonic and postnatal stages, the brains were sliced using a cryostat. First the brains were 
cryoprotected in 30% sucrose/PBS solution overnight and then embedded in Tissue-Tek and 
snap-frozen in dry ice. The frozen brains were then sectioned at a thickness of 14µm using a 
cryostat and collected on Superfrost glass slides. The slides were kept at -20°C until 
immunohistochemical analyses. 
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For postnatal and adult stages, the brains were sectioned with a vibratome. The brains were 
embedded in 4% agarose prepared in PBS and cut at a thickness of 70µm. The sections were 
stored in PBS. 
 
6.2.2.3 Immunostaining 
Cryosection and free-floating sections were immunostained using the same protocol as follows. 
Sections were first incubated in a solution of 0.1% Triton-X-100, 10% NGS in 0.1M PBS for 30 
minutes as a blocking step. Following this, they were incubated overnight at 4°C with primary 
antibodies diluted in the blocking solution. Primary antibodies used are listed below in the table. 
The next day, sections were washed 3 times in PBS and incubated with secondary antibodies 
(conjugated to a fluorophore and DAPI (4’, 6’ Diamidino-2-phenylindole) to visualize the nucleus, 
for 1.5 hours. The secondary antibodies and DAPI were also diluted in the blocking solution. The 
sections were again washed 3 times with PBS and mounted with Aqua Polymount.  
For certain antigen, additional steps were required to retrieve and unmask it prior to antibody 
incubation. To retrieve the Ctip2 and Ki67 antigens, the sections were boiled for 2-5 min in a 
microwave in 0.01M sodium citrate buffer and then rinsed in PBS a few times before incubation 
with the primary antibody. In the case of floating section, the sections were first mounted on slides 
prior to antigen retrieval. In the case of 5mC and 5hmC staining, the section needed to first be 
denatured with HCl. Thus, sections were first incubated with 2N HCl for 30 minutes followed by 2 
washes of 15 minutes with 100mM Tris-HCl buffer with pH 8.0.   
 
6.2.2.4 Fluorescence Activated Cell Sorting (FACS) 
Cortices from the electroporated E16 embryos were isolated and the midline and meninges were 
removed. The tissue was then enzymatically dissociated using 0.05% Trypsin for 15 minutes at 
37°c and resuspended in DMEM containing 10% fetal calf serum (FCS). The dissociated cells 
were then washed with PBS twice and filtered prior to analysis on the FACSAriaIII (BD 
bioscience). Gating parameters were determined by side and forward scatter to eliminate 
debris (P1 gate) and any aggregated cells (P2 gate). For isolation of GFP+ cells, the positive gate 
was set using non-electroporated tissue and set to include a maximum 0.1% of non-fluorescent 
cells. GFP+ve and GFP-ve cells were isolated using the purity mode and directly sorted into PBS.  
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For isolation of subpopulations (neural stem cells and neurons) at E14, the samples were first 
incubated with APC-conjugated Prominin-1 antibody (CD133, eBioscience) and PE-conjugated 
PSA-NCAM antibody (Miltenyi Biotec).  Additionally, a PE- and APC conjugated isotype 
control (eBioscience, Miltenyi Biotec) was used to set the positive gate for the stained populations. 
The cells were also isolated using the purity mode and into PBS and RLT buffer from the Qiagen 
micro RNeasy kit. 
 
6.2.3 Methods in Molecular Biology 
6.2.3.1 DNA Extraction from tail or ear 
To identify the genotype of animals, mice were genotyped by using DNA extracted from the tail 
or ear. The biopsies were incubated in 0.5ml DNA lysis buffer at 55 °C overnight or for 2 hours 
with shaking. After lysis, the debris was removed by centrifugation in at maximum speed for 10 
min. The supernatant containing DNA was precipitated using 0.5ml and centrifuged for 20min. 
The pellet was finally washed with 70% ethanol for 5 min and completely dried at room 
temperature. Finally, the DNA was eluted in 250µl double distilled H2O. 
 
6.2.3.2 Transformation of the competent bacteria 
Competent E.coli cells were used for the transformation of plasmid DNA. The cells were first 
thawed on ice and then about 100-500ng of DNA was added to the cells and incubated for 15 min 
on ice. The mixture was heat shocked for 30 sec at 42°c and immediately placed on ice for 5 min. 
250µl of pre-warmed LB medium was added to the transformation reaction mixture and the cells 
were then allowed to recover for 1 hour at 37°C with shaking. Finally, the cells were plated on LB-
ampicillin plates and incubated overnight at 37°c. 
6.2.3.3 Bacterial liquid cultures 
For small-scale plasmid DNA preparation, transformed colonies of bacteria were inoculated in 
5ml of LB-ampicillin and incubated overnight at 37°c. For large scale preparations, 1ml of the 5ml 
media was inoculated into 100ml of LB medium supplemented with ampicillin and incubated at 37 
°C with shaking. 
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6.2.3.4 DNA extraction from plasmids  
Plasmid DNA from 5ml bacterial cultures was extracted using the Qiagen miniprep kit and plasmid 
DNA from 100ml cultures was extracted using the Qiagen Maxiprep kit according to 
manufacturer’s protocols.  
 
6.2.3.5 Determination of the concentration and quality of nucleic acids 
The concentrations of nucleic acids were determined using the Nanodrop, which is a 
spectrophotometer that can measure the concentration of nucleic acids. Samples which had a 
260/280 ratio of between 1.8-2 were considered of good quality. 
The quality of RNA for RNAseq was further analyzed using the Agilent Bioanalyzer. Agilent 
Bioanalyzer can accurately measure ribosomal 18S, and 28S RNAs. It can then assign a RNA 
Integrity Number (RIN) that ranges from 1 (reflecting totally degraded RNA) to 10 (reflecting 
completely intact RNA). For RNAseq only high quality RNA (RIN > 8) samples were used. The 
bioanalyzer was also used to check the RNAseq and hmeDIPseq DNA library sizes.  
 
6.2.3.6 RNA extraction, cDNA synthesis and qPCR 
Total RNA was isolated using the Qiagen RNeasy kit for all qRT-PCR experiments using the 
manufacturer’s protocol, except the FACS sorted cells. In the case of FACS sorted cells, PicoPure 
RNA isolation kit from Thermo Scientific was used to extract RNA per the manufacturer’s protocol. 
cDNA synthesis was performed using random primers with the Maxima first strand synthesis kit 
(Thermo Scientific). Real-time qPCR was conducted using SYBR green and the Thermo Fisher 
Quant Studio 6 machine. qRT-PCR primers are listed in the primer’s section. Gapdh was used as 
a housekeeping gene. 
 
6.2.3.7 RNAseq - E16 ventricular zone 
Total RNA was extracted using QIAzol and the RNA clean and concentrator - 25 kit (Zymo 
Research) per the manufacterer’s protocol. Ribosomal RNA was depleted using the Ribogone 
mammalian kit from Clontech and the corresponding protocol. RNAseq libraries were prepared 
using SMARTer Stranded RNA-Seq Kit from Clontech for RNA concentrations between 10-100ng 
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per the kit protocol. Finally, quality control was carried out with a Bioanalyzer (Agilent) and 100bp 
paired end sequencing with a HiSeq sequencer (Illumina) at LAFUGA (Gene Center, Munich). 3 
biological replicates were used per genotype. 
 
6.2.3.8 RNAseq for E16 full cortex and P5 
Cerebral cortices were dissected from E16 embryos and postnatal day 5 pups. Total RNA was 
extracted using QIAzol and the RNA clean and concentrator – 25 kit (Zymo Research). Ribosomal 
RNA was depleted using the Ribozero gold kit for human/mouse/rat (Illumina) and the RNA clean 
and concentrator – 5 kit. Libraries were prepared using the NEBNext Ultra Directional RNA Library 
Prep Kit and the manufacturer’s protocol. Quality control was assessed with a Bioanalyzer 
(Agilent) and 100bp paired end sequencing was performed on a HiSeq sequencer (Illumina) at 
LAFUGA (Gene center, Munich, Germany). For P5 datasets, 3 biological replicates were used 
per genotype. For E16 full cortex, 2 biological replicates were used for cKO and 3 for controls.  
 
6.2.3.9 Oxidative Reduced Representation Bisulfite Sequencing 
Genomic DNA was extracted from the cerebral cortices of E16 controls and cKO using the 
DNeasy blood and tissue kit (Qiagen). 1 µg of mouse from each sample was first digested with 
MspI enzyme (NEB) at 37°C overnight. MspI enzyme digestion is enriched at CpG sites in the 
genome. The digested DNA was cleaned up with the MinElute Reaction Cleanup Kit (Qiagen) per 
the manufacturer´s instructions. Follwing this step, 500 ng of digested and purified DNA was used 
for preparing libraries with the NEXTflex™ Bisulfite Library Prep Kit (BIOO Scientific), per the 
manufacturer´s instructions with some modifications. To obtain an accurate analysis of 5mC and 
avoid false positives, we included a DNA oxidation step to account for the 5hmC. This oxidation 
step converts 5hmC to 5fmC but does not affect 5mC. Oxidation was performed with KRuO4 
(Sigma-Aldrich) according to published data (Booth et al. 2012). The bisulfite conversion of DNA 
was performed using the EZ Methylation Gold Kit (Zymo Research), following the manufacturer’s 
protocol. The libraries were purified using AMPure XP beads (Beckmann Coulter) and PCR 
amplification of the libraries was performed to assess positive and negative controls, with PfuCx 
Hot Start (Agilent). Finally, quality control with a Bioanalyzer (Agilent) was carried out and next-
generation sequencing with a HiSeq 1000 sequencer (Illumina Inc.) at a genomics core facility: 
Center of Excellence for Fluorescent Bioanalytics (KFB, University of Regensburg, Germany). 
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6.2.3.10 Oxidative Bisulfite sequencing 
Genomic DNA was extracted from E16 cortical tissue from controls and Uhrf1 cKO and Uhrf1 
floxed NS cells uninduced and induced with Cre protein, using the DNeasy blood and tissue kit 
(Qiagen). Oxidation and bisulfite conversion was performed as described in the above Ox-RRBS 
method. Loci specific PCR was performed on a 500bp region of IAP Gag and a 200bp region of 
LINE-1 (list of primers in the primers section of materials). The amplicons were adapter tagged 
using NEBNext Multiplex Oligos for Illumina (New England Biolabs). Briefly, 100-200 ng of 
amplicon and 62.5 pmol each of universal PCR primer and index primer were amplified in a total 
volume of 50 µL with NEBNext High-Fidelity PCR Master Mix (New England Biolabs) and the 
cycling conditions were 98°C/30"-[98°C/10"-65°C/30"-72°C/30"]x4-72°C/5'. PCR reactions were 
purified by using 80% (v/v) CleanPCR magnetic beads (GC biotech) and finally eluted using 25 
µL of water. In order to make all the fragments double stranded, a single round of amplification 
with P5 and P7 primers (Illumina) was added. To this end, 20 µL of the purified tagged amplicons 
and 25 pmol each of P5 and P7 primers were set up in a total reaction volume of 50 µL with 
Phusion Polymerase (New England Biolabs) according to the manufacturer's instructions. The 
PCR program used was 98°C/2'-60°C/1'-72°C/10'. Purification was the same as mentioned earlier 
with magnetic beads. Libraries were checked for quality control and correct fragment length on a 
Bioanalyzer 2100 (Agilent) and concentrations were determined with Qubit dsDNA HS Assay Kit 
(Life Technologies). Final sequencing was carried out on a MiSeq sequencer (2x300 bp paired 
end) with v3 chemistry (Illumina) at the Genomics Service Unit at LMU Biocenter. Primary 
sequencing reads were merged using CLC Genomics Workbench 9.0.1 (Qiagen) according to the 
following parameters: mismatch cost = 2; minimum score = 8; gap cost = 3; maximum unaligned 
end mismatches = 0. 
 
6.2.3.11 Hydroxy methylated DNA immunoprecipitation (hmeDIP) 
The germinal zones of cerebral cortices of E16 controls and cKO were dissected according the 
E16 GZ RNAseq workflow. Genomic DNA was then extracted as follows. The tissue was lysed 
using the gDNA lysis buffer (Tris, 0.5% SDS, EDTA). Following this, proteinase K was added to 
the samples and incubated for 2 hours. The gDNA was extracted using 2 rounds of 
phenol:chloroform: isoamyl alcohol extraction and 2 rounds of chloroform extraction to obtain the 
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aqueous phase everytime. This phase was precipitated with glycogen, 3M Sodium acetate and 
100% ethanol. The pellet was purified with 70% ethanol and eluted in DNAase free water. 
The protocol for hmeDIP was adapted from chapter 5 of book ‘DNA methylation:Methods and 
Protocols, second edition volume 507, 2009 – Fabio Mohn, Micheal Weber, Dirk Schubeler and 
Tim-Christoph Roloff (Tost. 2009) and from (Maunakea et al. 2010). Chromatin was sheared using 
the Covaris machine and assessed using the Bioanalyer (Agilent). For the immunoprecipitation, 
1ug of gDNA was used per sample. Briefly, the gDNA was denatured at 95°c and incubated 
overnight with the primary antibody, rotating at 4°c. The antibody bound sample was incubated 
with prewashed dynabeads for 2 hours at 4°c, rotating. The supernatant was washed 5 times with 
IP buffer, and eluted in the TE buffer. The sample was then de-crosslinked overnight at 55°c with 
proteinase K and finally purified with Qiagen PCR purification kit. The antibodies used for 
immunoprecipitation were 5mC (Millipore) and 5hmC (Active motif). DNA libraries were generated 
using the NEBNext Ultra DNA library preparation kit for Illumina. Quality control was carried out 
with a Bioanalyzer (Agilent) and 50bp single end sequencing with a HiSeq sequencer (Illumina) 
at LAFUGA. N= 3-4 embryos for each genotype. The samples were pooled to obtain one sample 
per genotyped which was immunoprecipitated and sequenced. 
 
6.2.3.12 Genotyping by Polymearse Chain Reaction (PCR) 
Reaction mix         2.5 µl 10x buffer  
                              5µl Q-Solution (Qiagen) 
                              0.5µl dNTPs, 
                              1µl each Primer  
                              0.2µl Taq Polymerase 
                              1 µl DNA 
                              upto 25µl with H2O      
                                            
Emx1-Cre mice 
The genotyping protocol of the Emx1::Cre mice was adapted from (Iwasato et al. 2000). 
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                   94°C                 2 min 
                   94°C               30 sec                    Band size : WT  200bp ; transgenic 500bp        
 35X           65°C                 1 min 
                   72°C               30 sec 
                   72°C               10 min 
 
CAG CAT eGFP mice  
The genotyping protocol of the CAG CAT eGFP mice was adapted from (Nakamura et al. 2006). 
                   94°C                 5 min 
                   94°C               30 sec                    Band size : 350bp 
 29X           55°C               30 sec 
                   72°C               1 min 
                   72°C               10 min 
 
GlastCreERT2 mice 
 
The genotyping protocol of the Glast::CreERT2 mice was adapted from (Mori et al. 2006) 
 
                   94°C               2 min 
                   94°C               20 sec               Band size: WT 700 bp; Recombinant 400 bp 
 35X           55°C               20 sec 
                   72°C               30 sec 
                   72°C                 5 min 
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6.2.3.12.4    Uhrf flox / flox mice  
The genotyping protocol was established according to the protocol received from EUCOMM 
                   95C                5min 
                   94°C               30 sec               Band size: WT  = 331bp    ; Recombinant  = 523 bp 
 39 X          65°C               45 sec 
                   72°C               45sec 
                   72°C               10 min 
                  
 
6.2.3.13 Gel Electrophoresis  
The percentage of the agarose gel depends on the size of the nucleic acid of interest. The 
appropriate amount of agarose was dissolved in 1X TAE buffer by boiling in a microwave to obtain 
a 1% or 0.5% gel. After slight cooling, SYBR safe DNA stain was added in the concentration of 
1:25,000 and the gel was poured into a prepared gel chamber. Once the gel solidified, DNA or 
RNA samples mixed with 6X loading dye and loaded into the wells, alongwith a 1kb DNA ladder. 
Electrophoresis was performed between 70-100V.  
 
For the Ox-BS experiments the DNA fragments with the right size were excised using UV light 
(254 nm) and purified using the QIAquick gel extraction kit (Qiagen), according to the 
manufacturer’s protocol.  
 
6.2.3.14 Western blotting and mass spectrometry 
Protein was extracted from E16 cerebral cortices of controls and cKO as follows. The tissue pellet 
was resuspended in 200-300 microlitres of Tween 20 lysis buffer, placed on ice for 30 minutes 
and pelleted at 2500 rpm. The supernatant was collected as the cytoplasmic fraction. The pellet 
was washed with Tween 20 lysis buffer with 500mM NaCl twice and resuspended in 100 
microlitres of this solution. The sample was sonicated for a few seconds at low intensity. The 
sample was incubated on ice for 15 minutes and another 100 microlitres of tween 20 lysis buffer 
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without NaCl was added. The sample was centrifuged at 10,000g for 15 minutes at 4°c and the 
supernatant was recovered as the nuclear fraction.  
Protein was quantified using the Pierce BCA protein assay kit. Western blot was performed by 
first running the proteins on a 10% Bis-acrylamide gel (30 % (w/v) Acrylamide/Bis Solution, 20 % 
(w/v) SDS, 10 % (w/v) APS and TEMED) with a separation gel buffer (1.5 M Tris/HCl, pH 8.8) and 
stacking gel buffer (0.5 M Tris/HCl, pH 6.8) on a Mini Protean Tetra System and transferred into 
nitrocellulose membranes using the 1X transfer buffer. The blotted membranes were washed with 
0.5% Tween 20/PBS (TBST) and blocked for 30 minutes with 5% milk/TBST. The primary 
antibodies were incubated overnight at 4°c and washed 3 times with TBST. Following secondary 
antibody incubation, the membranes were visualized using the ECL substrate. The protein 
samples for mass spectrometry were analysed at the Proteomics Unit at the Helmholtz Zentrum 
Munich. Further analysis was performed using the Scaffold software. 
 
6.2.3.15 Methylation digests 
Genomic DNA was extracted from E16 cerebral cortices using the extraction method for 
5hmeDIP. 500ng of DNA was digested with HpaII and MspI using the EpiJET DNA methylation 
kit according the manufacterer’s protocol. The digested DNA was run on a 0.5% agarose gel. 
 
6.2.4 Data Analysis  
6.2.4.1 Bioinformatic analyses  
RNA-seq  
RNA-seq reads (100bp paired-end) were mapped to the mouse genome (mm10) using tophat2 
(Kim et al. 2013), resulting in alignments with minimal mismatches. The resulting BAM files were 
filtered to allow only reads in a proper pair and to remove reads with multiple mapping in the 
genome as well as duplicated reads and low quality alignments using samtools (-F 2 -f 
1280). Expression of genes in FPKM was calculated with cuffdiff and cummerbund (Trapnell et 
al. 2013). Regulated genes were selected based on the cufflinks p-value (p<0.05) and change in 
expression (> 2 fold). Genes indicated as derepressed were selected based on very low 
expression in control (FPKM < 0.1) and higher expression in cKO (FPKM > 0.1). Dot plots were 
generated with ggplot2. Gene set enrichment analysis of differentially expressed genes was 
performed as described (Mootha et al. 2003; Subramanian et al. 2005).   
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For expression analysis of individual repeat elements, filtered BAM files were converted to homer 
tag directories using makeTagDirectory. For individual IAP elements, the genomic positions were 
extracted from the rmsk dataset (UCSC). The coverage across repeat families and individual 
repeats was analyzed using analyzeRepeats (Heinz et al. 2010).  
Genes which might regualted by activated IAP elements were identified by (1) selecting the 
upregulated genes (fold change > 2); and (2) testing for activated IAP elements within a certain 
distance of upregulated genes (+/- 50.000 bp).  
 
Hydroxy-meDIP  
Hydroxy-MeDIP reads (50bp single end) were mapped to the mouse genome (mm10) using 
bowtie with options -q –n 2 --best. These resulting SAM files were converted to homer tag 
directories using makeTagDirectory (Heinz et al. 2010). The cumulative IAP coverage plots 
depicted were generated as in (Sadic et al. 2015). 
 
Oxidative Reduced Representation Bisulfite Sequencing 
All reads generated were mapped to the mouse genome version GRCm38 with the commercially 
available Genomatix software (version 2.2.2 Genomatix) allowing no mismatch in sequence. For 
analysis of the control sequences and the cKO status, a custom mapping library with the 
methylated and unmethylated DNA sequences of the PCR products and vector was generated. 
The methylation status per CpG or CpH was extracted, positions with a coverage = < 5 were 
excluded. Data analysis was then performed with custom scripts using the free software R ver. 
3.1.1 and the package methylkit (Akalin et al. 2012). For the analysis of differentially methylated 
regions, the region length was set to 100 bp in length. 
Genomatix was used to predict promoter regions that were used for the differential methylation 
analysis.  
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Oxidative Bisulfite sequencing 
All reads generated were filtered for size (490bp to 510bp for IAP and 250-270bp for LINE-1) 
using Perl. 300 independent PCR products were subsampled for each genotype and analysed 
with QUMA software for their methylation status per CpG. % of 5hmC was inferred from the 
difference between oxidized and unoxidised samples, within each genotype.  
 
6.2.4.2 Data analysis of immunostainings and qRT-PCR 
In vivo stainings were analyzed at an Olympus FV1000 laser-scanning confocal microscope. In 
vitro stainings were analyzed on a Zeiss epifluoroscence microscope. 
All error bars are presented as standard errors of the mean (± SEM). Statistical significance was 
tested using the Mann-Whitney test for immunostainings and Annexin assay.  
For immunostaining experiments without quantifications, a minimum of 3 embryos/animals per 
genotype was analyzed. 
For all qRT-PCR experiments, data was analysed with a unpaired t-test, except in the Tet 
knockdown experiments wherein a paired t-test was used. All ‘n’ refers to individual embryos or 
animals. 
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7. Abbreviations 
  
%                      Percent 
°C                     Degree Celsius 
µg                    Microgram(s) 
µl                     Microlitre(s) 
µM                   Micromolar 
5mC                5-methyl cytosine 
5hmC              5-hydroxy methyl cytosine 
5CaC               5-carboxyl methyl cytosine 
5fC                  5-formyl methyl cytosine 
aNSCs            Adult neural stem cells 
AP                   Apical Progenitor 
bHLH              Basic helix-loop-helix 
BP                  Basal Progenitor 
Bp                  Base pairs 
CC                  Corpus callosum 
cDNA             Complementary Deoxyribonucleic Acid 
cKO               Conditional knock out 
CNS               Central Nervous System 
Ctx                Cortex 
CP                 Cortical plate 
Cux1             Cut-Like homeobox 1 
DAPI             4',6-diamidino-2-phenylindole 
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dATP            DeoxyAdenosine TriPhosphate 
dCTP            DeoxyCytidine TriPhosphate 
Dcx              Doublecortin 
DG               Dentate Gyrus 
dGTP           DeoxyGuanosine TriPhosphate 
Dnmt           DNA methytransferase  
DMEM         Dulbecco's Modified Eagle Medium 
DNA            Deoxyribonucleic Acid 
dNTP          DeoxyNucleoside TriPhosphate 
dTTP          DeoxyThymidine TriPhosphate 
dpi              days post-induction 
E                 Embryonic Day 
e.g.             For example (Latin ‘exempli gratia’) 
EDTA         Ethylene-Diamine-tetra-Acetic-Acid 
EGF            Epidermal Growth Factor 
Emx1/2       Empty spiracles homeobox 1/2 
ERV            Endogeneous retroviral elements 
FCS            Fetal Calf Serum 
FDR           False discovery rate 
FPKM        Fragment Per Kilobase of transcript per Million mapped reads 
FGF           Fibroblast growth factor 
FSC-A       Forward scatter–area 
FSC-W      Forward scatter- width 
G               Gram 
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GAPDH     GlycerAldehyde 3-Phosphate DeHydrogenase 
GE             Ganglionic Eminence 
GFAP        Glial Fibrillary Acidic Protein 
GFP          Green Fluorescent Protein 
GLAST     Glutamate Aspartate Transporter 
H               Hour(s) 
HBSS        Hank’s balanced salt solution 
HCl           Hydrochloric acid 
HDAC1     Histone deactylase 1 
HEPES     4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
het            heterozygous 
IAP           Intracisternal A-Particle  
Kb            Kilobase 
kDa          Kilodalton 
Kg            Kilogram(s) 
L               Litre 
LB            Luria-Bertani medium 
LGE         Lateral Ganglionic Eminence 
MGE        Medial Ganglionic Eminence 
Min          Minute 
mM          Millimolar 
mRNA     Messenger Ribonuicleic Acid 
NaCl        Sodium Chloride 
Ng           Nanogram(s) 
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OB         Olfactory Bulb 
Olig2     Oligodendrocyte transcription factor2 
OPCs    Oligodentrocyte progenitor cells 
P            Postnatal day 
Pax6      Paired box 6 
PBS       Phosphate Buffered Saline 
PCR       Polymerase Chain Reaction 
P/S         Penicillin/Streptomycin 
PFA       Paraformaldehyde 
PH3       Phospho-Histone 3 
PHD      Plant Homeodomain 
qPCR    Quantitative Polymerase Chain Reaction 
RG        Radial Glia 
RIN       RNA integrity number 
RING    Really Interesting New Gene 
RMS     Rostral Migratory Stream 
RNA     Ribonucleic Acid 
rpm      Revolutions per minute 
RPKM  Reads Per Kilobase of transcript per Million mapped reads 
RT        Room Temperature 
Sec      Seconds 
SDS     Sodium dodecyl sulphate 
SEM     Standard Error of the Mean 
SEZ      Subependymal Zone 
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SP        Subapical Progenitor 
SVZ     Subventricular Zone 
TAE     Tris Acetate EDTA 
Taq      DNA polymerase of bacterium Thermus aquaticus 
Tbr       T-box brain 
Tet       Ten-eleven-translocase 
TF        Transcription factor 
TTD      Tandem Tudor Domain 
TUNELTerminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling 
U          Enzyme unit 
Uhrf1   Ubiquitin-like, containing PHD and RING finger domains, 1 
VZ        Ventricular Zone 
w/v       Weight/Volume 
WT       Wild Type 
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